<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006934.pub2" GROUP_ID="INCONT" ID="292007020715045642" MERGED_FROM="" MODIFIED="2012-11-07 11:39:03 +0000" MODIFIED_BY="Muhammad Imran Omar" REVIEW_NO="0001" REVMAN_SUB_VERSION="5.1.7" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="4.1">
<COVER_SHEET MODIFIED="2012-11-07 11:39:03 +0000" MODIFIED_BY="Muhammad Imran Omar">
<TITLE MODIFIED="2010-02-16 11:11:04 +0000" MODIFIED_BY="[Empty name]">Simple urethral dilatation, endoscopic urethrotomy, and urethroplasty for urethral stricture disease in adult men</TITLE>
<CONTACT MODIFIED="2012-11-07 11:39:03 +0000" MODIFIED_BY="Muhammad Imran Omar"><PERSON ID="FB2C177782E26AA2002F1D7A98A3C422" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Omar</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Aboumarzouk</LAST_NAME><POSITION>Urology Registrar</POSITION><EMAIL_1>aboumarzouk@gmail.com</EMAIL_1><EMAIL_2>drbigo31262@gmail.com</EMAIL_2><MOBILE_PHONE>(0044) 7886885677</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Urology</DEPARTMENT><ORGANISATION>Wales Deanery</ORGANISATION><ADDRESS_1>40 Hollybush Road</ADDRESS_1><ADDRESS_2>Cyncoed</ADDRESS_2><CITY>Cardiff</CITY><ZIP>CF23 6TA</ZIP><REGION>Wales</REGION><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2012-11-07 11:39:03 +0000" MODIFIED_BY="Muhammad Imran Omar"><PERSON ID="3D45F4C382E26AA20164DA25E1FA3117" ROLE="AUTHOR"><FIRST_NAME>Susan</FIRST_NAME><MIDDLE_INITIALS>SW</MIDDLE_INITIALS><LAST_NAME>Wong</LAST_NAME><POSITION>Speciality Registrar in Urology</POSITION><EMAIL_1>s.wong@ncl.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Department of Urology</DEPARTMENT><ORGANISATION>Freeman Hospital</ORGANISATION><CITY>Newcastle-upon-Tyne</CITY><ZIP>NE7 7DN</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 7711327377</PHONE_1></ADDRESS></PERSON><PERSON ID="FB2C177782E26AA2002F1D7A98A3C422" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Omar</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Aboumarzouk</LAST_NAME><POSITION>Urology Registrar</POSITION><EMAIL_1>aboumarzouk@gmail.com</EMAIL_1><EMAIL_2>drbigo31262@gmail.com</EMAIL_2><MOBILE_PHONE>(0044) 7886885677</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Urology</DEPARTMENT><ORGANISATION>Wales Deanery</ORGANISATION><ADDRESS_1>40 Hollybush Road</ADDRESS_1><ADDRESS_2>Cyncoed</ADDRESS_2><CITY>Cardiff</CITY><ZIP>CF23 6TA</ZIP><REGION>Wales</REGION><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="9CA7244F82E26AA2003ED3F51F402E49" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Radhakrishna</FIRST_NAME><LAST_NAME>Narahari</LAST_NAME><POSITION>Specialist Training Year 2 Urology, Northern Deanery</POSITION><EMAIL_1>knrkrishna@yahoo.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Urology</DEPARTMENT><ORGANISATION>Wansbeck General Hospital</ORGANISATION><ADDRESS_1>Woodhorn Lane</ADDRESS_1><CITY>Ashington</CITY><REGION>NE63 9JJ</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 191 2812442</PHONE_1><PHONE_2>+44 7906083792</PHONE_2></ADDRESS></PERSON><PERSON ID="9CA9FE7982E26AA2003ED3F5B92C7EF4" ROLE="AUTHOR"><PREFIX>Miss</PREFIX><FIRST_NAME>Anna</FIRST_NAME><LAST_NAME>O'Riordan</LAST_NAME><POSITION>Specialist Registrar</POSITION><EMAIL_1>aorior@yahoo.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Urology</DEPARTMENT><ORGANISATION>Freeman Hospital</ORGANISATION><ADDRESS_1>Freemand Road</ADDRESS_1><ADDRESS_2>High Heatong</ADDRESS_2><CITY>Newcastle Upon Tyne</CITY><ZIP>NE7 7DN</ZIP><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="14256" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Robert</FIRST_NAME><LAST_NAME>Pickard</LAST_NAME><POSITION>Consultant Urologist</POSITION><EMAIL_1>robert.pickard@newcastle.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Institute of Cellular Medicine</DEPARTMENT><ORGANISATION>Newcastle University</ORGANISATION><CITY>Newcastle upon Tyne</CITY><ZIP>NE7 7DN</ZIP><REGION>Tyne and Wear</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 191 2336161 ext: 26139</PHONE_1><FAX_1>+44 191 2130205</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2012-11-07 09:16:42 +0000" MODIFIED_BY="Omar Aboumarzouk">
<UP_TO_DATE>
<DATE DAY="21" MONTH="6" YEAR="2012"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="21" MONTH="6" YEAR="2012"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="30" MONTH="6" YEAR="2014"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2008"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2010"/>
<LAST_CITATION_ISSUE ISSUE="4" YEAR="2010"/>
</DATES>
<WHATS_NEW MODIFIED="2012-11-07 09:19:50 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2012-11-07 09:19:50 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="7" MONTH="11" YEAR="2012"/>
<DESCRIPTION>
<P>Literature search was updated. No additional trial was identified.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2012-11-07 09:19:41 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="7" MONTH="11" YEAR="2012"/>
<DESCRIPTION>
<P>Literature search was updated. No additional trial was identified.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2010-01-19 11:38:48 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-01-19 11:38:48 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="28" MONTH="10" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2009-08-06 21:14:36 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2009-08-06 21:14:36 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2009-08-06 21:14:36 +0100" MODIFIED_BY="[Empty name]">
<NAME>Department Of Urology, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2009-08-06 21:14:26 +0100" MODIFIED_BY="[Empty name]">
<NAME>Cochrane Incontinence Group, Universtiy of Aberdeen, Aberdeen</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2012-11-07 10:05:45 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2012-11-07 09:50:07 +0000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2012-09-16 22:16:53 +0100" MODIFIED_BY="[Empty name]">Blind stretching or telescopic cutting versus open surgery for urethral narrowing in men</TITLE>
<SUMMARY_BODY MODIFIED="2012-11-07 09:50:07 +0000" MODIFIED_BY="[Empty name]">
<P>Narrowing of the urine pipe (urethral stricture) is a common cause of problems in passing water for younger men. Standard treatment consists of widening the strictured segment using instruments passed down the urethra (called urethral dilatation or urethrotomy). Alternatively, a urethroplasty operation can be performed whereby the narrowed area is removed or replaced by graft material. The uncertainty as to which option is best prompted this review of the current evidence. We found very little good quality evidence and were unable to achieve all our objectives for this review. The results of a single study suggest that dilatation and urethrotomy offer equivalent outcomes, but they are associated with a high rate of recurrence of the stricture requiring repeated procedures over a relatively short period of time. Preliminary data reported in abstract form suggested that urethroplasty was more effective than urethrotomy for the specific circumstance of urethral trauma following fracture of the pelvic bones. We found no data concerning well-being or the quality of life amongst men treated for urethral stricture disease. The main conclusion of the review is that the current lack of quality evidence means that further trials are needed to establish which intervention is most effective and most cost-effective for treatment of urethral stricture disease in men. </P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2012-11-07 09:49:40 +0000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2012-11-07 09:48:29 +0000" MODIFIED_BY="[Empty name]">
<P>Strictures of the urethra are the most common cause of obstructed micturition in younger men and frequently recur after initial treatment. Standard treatment comprises internal widening of the strictured area by simple dilatation or by telescope-guided internal cutting (optical urethrotomy), but these interventions are associated with a high failure rate requiring repeated treatment. The alternative option of open urethroplasty whereby the urethral lumen is permanently widened by removal or grafting of the strictured segment is less likely to fail but requires greater expertise. Findings of Improved choice of graft material and shortened hospital stay suggest that urethroplasty may be under utilised. The extent and quality of evidence guiding treatment choice for this condition are uncertain.  </P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2010-02-15 11:18:32 +0000" MODIFIED_BY="[Empty name]">
<P>To determine which is the best surgical treatment for male urethral stricture disease taking into account relative efficacy, adverse event rates and cost-effectiveness.  </P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2012-11-06 10:17:51 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Incontinence Group Specialised Register (searched 21 June 2012), CENTRAL (2012, Issue 6), MEDLINE (January 1946 to week 2 June 2012), EMBASE (January 1980 to week 25 2012), OpenSIGLE (searched 26 June 2012), clinical trials registries and reference lists of relevant articles.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2009-07-21 00:28:17 +0100" MODIFIED_BY="[Empty name]">
<P>We included publications reporting data from randomised or quasi-randomised controlled trials comparing the effectiveness of dilatation, urethrotomy and urethroplasty in the treatment of adult men with urethral stricture disease.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2012-11-07 09:48:37 +0000" MODIFIED_BY="[Empty name]">
<P>Two authors evaluated trials for appropriateness for inclusion and methodological quality. Data extraction was performed using predetermined criteria. Analyses were carried out using the Cochrane Review Manager software (RevMan 5).</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2012-11-07 09:49:36 +0000" MODIFIED_BY="[Empty name]">
<P>Two randomised trials were identified. One trial compared the outcomes of surgical urethral dilatation and optical urethrotomy in 210 adult men with urethral stricture disease. No significant difference was found in the proportion of men being stricture free at three years or in the median time to recurrence. The second trial compared the outcomes of urethrotomy and urethroplasty in 50 men with traumatic stricture of the posterior urethra following pelvic fracture injury. In the first six months, men were more likely to require further surgery in the urethrotomy group than in the primary urethroplasty group (RR 3.39, 95% CI 1.62 to 7.07). After two years, 16 of 25 (64%) men initially treated by urethrotomy required continued self-dilatation or further surgery for stricture recurrence compared to 6 of 25 (24%) men treated by primary urethroplasty. There were insufficient data to perform meta-analysis or to reliably determine effect size.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2012-11-07 09:49:40 +0000" MODIFIED_BY="[Empty name]">
<P>There were insufficient data to determine which intervention is best for urethral stricture disease in terms of balancing efficacy, adverse effects and costs. Well designed, adequately powered multi-centre trials are needed to answer relevant clinical questions regarding treatment of men with urethral strictures.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2012-11-07 10:05:45 +0000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2012-11-07 09:53:17 +0000" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2012-11-07 09:51:08 +0000" MODIFIED_BY="[Empty name]">
<P>Urethral strictures are sections of tightening of the urethra that give rise to slowing down or blocking of the urinary flow causing irritative or obstructive voiding symptoms. They are a common sequel to urethral endoscopic procedures, such as cystoscopy and catheterization, that cause trauma to the urethral tract and fibrosis and healing, which can lead to stricture formation (<LINK REF="REF-Mathur-2011" TYPE="REFERENCE">Mathur 2011</LINK>). Other less common causes include external blunt perineal trauma, sexually transmitted disease, or lichen sclerosus (<LINK REF="REF-Singh-2011" TYPE="REFERENCE">Singh 2011</LINK>).</P>
<P>Urethral strictures can be divided into anterior or posterior strictures depending on the anatomical location (<LINK REF="REF-Ibrahim-2012" TYPE="REFERENCE">Ibrahim 2012</LINK>; <LINK REF="REF-Singh-2011" TYPE="REFERENCE">Singh 2011</LINK>). All strictures from the bulbar urethra and distally are anterior, while those that are more proximal are posterior strictures.</P>
<P>The main symptoms include poor stream, dribbling, increased frequency, prolonged voiding, haematuria, incontinence of urine, recurrent urinary tract infections, urinary retention and, in rare cases, urethral carcinoma, Fournier's gangrene, and bladder atonia (<LINK REF="REF-Anger-2010" TYPE="REFERENCE">Anger 2010</LINK>).</P>
<P>The mainstay of treatment depends on the patient, and consists of intermittent self-catheterization or procedures for urethral dilatation, urethrotomy, or urethroplasty. This review covers dilatation, urethrotomy, and urethroplasty, and another Cochrane review (in preparation) will cover intermittent self-catheterization (<LINK REF="REF-Jackson-2012" TYPE="REFERENCE">Jackson 2012</LINK>). </P>
</CONDITION>
<INTERVENTION MODIFIED="2012-11-07 09:51:59 +0000" MODIFIED_BY="[Empty name]">
<P>Simple blind dilatation of a urethral stricture to disrupt and widen the scarred area has been practiced for many centuries (<LINK REF="REF-Attwater-1943" TYPE="REFERENCE">Attwater 1943</LINK>). Metal, gum elastic, or plastic rods of increasing diameter are sequentially passed down the lubricated urethra until an adequate lumen, usually about 8 mm in diameter, is achieved (<LINK REF="REF-Devereux-1970" TYPE="REFERENCE">Devereux 1970</LINK>). The blind nature of the procedure can, however, lead to further damage to the urethra increasing the degree of scarring. This drawback led to development of an endoscope with an attached knife that could be passed down the urethra. A longitudinal cut is made in the strictured area under direct vision so widening the lumen, termed optical urethrotomy (<LINK REF="REF-Sachse-1973" TYPE="REFERENCE">Sachse 1973</LINK>). This has become standard care in countries with access to appropriate endoscopic equipment. Despite the increased accuracy of this technique at least 50% of men will develop a recurrent stricture requiring repeated procedures over a lifetime (<LINK REF="REF-Holm_x002d_Nielsen-1984" TYPE="REFERENCE">Holm-Nielsen 1984</LINK>). Urethroplasty is an open surgical technique whereby the strictured segment is identified through an appropriate skin incision and the urethra repaired either by removing the affected area and joining the two ends together (anastomotic urethroplasty) or by opening the narrowed part longitudinally and incorporating graft material to keep the lumen open (substitution urethroplasty) (<LINK REF="REF-Andrich-2008" TYPE="REFERENCE">Andrich 2008</LINK>). This review considered the available evidence to compare the effectiveness of dilatation, optical urethrotomy, and urethroplasty for treatment of urethral stricture disease.</P>
</INTERVENTION>
<THEORY MODIFIED="2012-11-07 09:52:18 +0000" MODIFIED_BY="[Empty name]">
<P>Simple dilatation disrupts the annular scar that forms the stricture in multiple planes. The assumption is that the multiple tears heal by epithelialisation with healthy mucosa. Unfortunately, if the area heals with further scar tissue then the stricture is likely to recur. Urethrotomy, on the other hand, results in a linear longitudinal scar incision in a single plane. It is hoped that this controlled single division is more likely to result in natural scar-free healing. Ideally an anastomotic technique is used for open urethroplasty whereby the strictured urethral segment is completely excised and the two healthy ends joined together. Unfortunately this can only be done if the abnormal urethra is less than 2 cm in length. Since the unhealthy scar tissue is generally more extensive, a technique of partial urethral substitution is more commonly used. Here the urethra is opened longitudinally centred on the scarred area and extending into healthy tissue above and below. A patch of graft material, usually penile skin or buccal mucosa, is then stitched into the defect. The mature graft acts as a bridge of healthy tissue keeping the scarred edges apart and maintaining a normal calibre of the urethral lumen.  </P>
</THEORY>
<IMPORTANCE MODIFIED="2012-11-07 09:53:17 +0000" MODIFIED_BY="[Empty name]">
<P>Urethral strictures continue to be predominantly treated throughout the world by either simple blind dilatation or by endoscopic urethrotomy repeated as and when needed. This treatment tends to manage rather than cure the condition and may be associated with long term adverse effects and long term costs. In the past urethroplasty was considered to be a difficult operation and was reserved for complex cases but the recent use of buccal mucosa harvested from the mouth as graft material and streamlined peri-operative care pathways that reduce hospital stay to less than 48 hours have suggested a wider role for the procedure (<LINK REF="REF-O_x0027_Riordan-2008" TYPE="REFERENCE">O'Riordan 2008</LINK>). This may be particularly appropriate as open urethroplasty appears to be associated with a lower recurrence rate than optical urethrotomy (<LINK REF="REF-Andrich-2000" TYPE="REFERENCE">Andrich 2000</LINK>). Expert opinion suggests that open urethroplasty may be more effective than the current standard of optical urethrotomy but with equivalent costs and adverse effects (<LINK REF="REF-Rourke-2005" TYPE="REFERENCE">Rourke 2005</LINK>). There is also debate as to whether urethroplasty could be used as initial treatment for men with newly diagnosed strictures or it should be reserved for men with recurrent disease following initial endoluminal treatment (<LINK REF="REF-Greenwell-2004" TYPE="REFERENCE">Greenwell 2004</LINK>). Activity data from the National Health Service in England suggest that urethroplasty is under utilised, with only 500 procedures carried out in 2006 against 7000 urethrotomy and urethral dilatation procedures (www.hesonline.nhs.uk). We therefore wish to systematically review the available literature to determine whether current evidence is sufficient to guide patients, clinicians, and the NHS as to best practice or whether further research is required. </P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2012-11-07 09:53:20 +0000" MODIFIED_BY="[Empty name]">
<P>To determine, based on current evidence, which intervention for urethral stricture in adult men is best in terms of efficacy, adverse effects, and cost.</P>
<P>Specific comparisons to be made are as follows:</P>
<P>1. urethrotomy versus urethral dilatation;<BR/>2. urethrotomy versus urethroplasty;<BR/>3. urethral dilatation versus urethroplasty.<BR/>
</P>
</OBJECTIVES>
<METHODS MODIFIED="2012-11-07 09:54:33 +0000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2012-11-07 09:53:35 +0000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2012-11-07 09:53:25 +0000" MODIFIED_BY="[Empty name]">
<P>We included any relevant published data from randomised or quasi-randomised controlled trials (RCTs) that compared two or more of these interventions in the treatment of adult urethral stricture disease. These could be published either in full text or in an abstract form.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2012-11-07 09:53:28 +0000" MODIFIED_BY="[Empty name]">
<P>Studies including adult men (aged greater than 18 years) with primary or recurrent urethral stricture irrespective of anatomical site, length, aetiology, or number of previous interventions were included.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2012-11-06 10:18:41 +0000" MODIFIED_BY="[Empty name]">
<P>We systematically reviewed the literature comparing the following three surgical interventions:</P>
<P>1. urethrotomy (optical cold knife urethrotomy);<BR/>2. simple urethral dilatation;<BR/>3. urethroplasty (anastomotic or substitution).</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2012-11-07 09:53:35 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome measure</HEADING>
<P>Proportion of men requiring further surgery for stricture recurrence</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcome measures</HEADING>
<P>1. Interval between initial intervention and need for further treatment<BR/>2. Improvement in symptoms<BR/>3. Adverse events including infection, bleeding, incontinence, and erectile dysfunction<BR/>4. Quality of life improvement<BR/>5. Costs including resource use and estimates of cost-effectiveness<BR/>
</P>
</SUBSECTION>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2012-11-07 09:53:35 +0000" MODIFIED_BY="[Empty name]">
<P>We did not impose any language or other restrictions on the searches, which are described below.</P>
<ELECTRONIC_SEARCHES MODIFIED="2012-11-06 10:20:05 +0000" MODIFIED_BY="[Empty name]">
<P>This review has drawn on the search strategy developed for the Cochrane Incontinence Review Group. Relevant trials were identified from the Incontinence Group Specialised Register of controlled trials which is described under the Incontinence Group's <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/INCONT/frame.html">module</A> in <I>The Cochrane Library</I>. The register contains trials identified from MEDLINE, CINAHL, the Cochrane Central Register of Controlled Trials (CENTRAL) and handsearching of journals and conference proceedings. The date of the most recent search of the Specialised Register for this review was 21 June 2012. </P>
<P>The trials in the Incontinence Group Specialised Register are also contained in CENTRAL.</P>
<P>The terms used to search the Incontinence Group Specialised Register are given below:</P>
<P>({DESIGN.CCT*} OR {DESIGN.RCT*}) AND ({topic.urine.urethralStricture.})</P>
<P>(All searches were of the keyword field of Reference Manager 12, Thomson Reuters).</P>
<P>For this review additional searches were performed by the Trials Search Co-ordinator. These are detailed below.</P>
<P>The following databases were searched:</P>
<UL>
<LI>CENTRAL (2012, Issue 6), searched on 21 June 2012;</LI>
<LI>MEDLINE (January 1946 to week 2 June 2012), searched on 21 June 2012;</LI>
<LI>MEDLINE In Process (20 June 2012), searched on 21 June 2012;</LI>
<LI>EMBASE (January 1980 to Week 25 2012), searched on 25 June 2012;</LI>
<LI>OpenSIGLE, searched on 26 June 2012.</LI>
</UL>
<P>The following clinical trials registries or platforms were also searched on 26 June 2012:</P>
<UL>
<LI>WHO International Clinical Trials Registry Platform (ICTRP);</LI>
<LI>Current Controlled Trials (including the UK National Research Register);</LI>
<LI>ClinicalTrials.gov.</LI>
</UL>
<P>The search terms used in all these databases are given in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2012-11-06 10:20:30 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the reference lists of relevant articles for other possibly relevant trials.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2012-11-07 09:54:33 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Selection of studies</HEADING>
<P>Identified studies were selected for inclusion in the review on the basis of appropriateness, as determined by two independent review authors, without prior consideration of the results. Non-English language publications were translated if required. Two review authors independently assessed the methodological quality of the studies using risk of bias criteria including quality of randomisation and allocation concealment, description of withdrawals and dropouts, and use of intention-to-treat analysis. Any disagreements were resolved by discussion and, if necessary, referred to an arbiter. Studies were excluded from the review if they were not randomised or quasi-randomised, or if on more detailed examination they did not meet the review inclusion criteria. These studies are listed in the 'Characteristics of excluded studies' table.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Data extraction and management</HEADING>
<P>Data were independently extracted by two review authors and cross-checked. Included study results were processed as described in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2009" TYPE="REFERENCE">Higgins 2009</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Data analyses</HEADING>
<P>We were not able to perform meta-analyses as only one study was included in each comparison. Where sufficient data were reported, individual study estimates were generated in RevMan using risk ratios (RR) and 95% confidence intervals (CI) for dichotomous outcomes.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup Analyses</HEADING>
<P>The following subgroup analyses were planned but insufficient data were available in the reports.</P>
<P>1. Length of the stricture: less than 2 cm versus more than 2 cm.<BR/>2. Location of the stricture: bulbar versus penile.<BR/>3. Number of previous interventions: two or more versus less than two.</P>
</SUBSECTION>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2012-11-07 10:03:00 +0000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2012-11-07 09:59:44 +0000" MODIFIED_BY="[Empty name]">
<P>See: 'Characteristics of included studies' table.</P>
<SEARCH_RESULTS MODIFIED="2012-11-07 09:54:43 +0000" MODIFIED_BY="[Empty name]">
<P>A total of 1693 reports of studies were retrieved by the searches, of which 31 were identified by initial screening for consideration with regard to inclusion in the review. <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> depicts the study selection process. The sources of the retrieved studies were as follows: Specialised Register, 52 references; CENTRAL (2012, Issue 1) searched on 27 May 2012, 131 references; MEDLINE (January 1950 to May 2012) searched on 27 May 2012, 503 references; MEDLINE In Process (26 May 2012), searched on 27 May 2012, 18 references; EMBASE (January 1980 to May 2012) searched on 27 May 2012, 877 references; OpenSIGLE searched on 27 May 2012, 66 references; WHO ICTRP, 2 references; Current Controlled Trials (including the UK National Research Register), 38 references; ClinicalTrials.gov, 6 references; and searching of conference proceedings, 1 reference.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2012-11-07 09:58:59 +0000" MODIFIED_BY="[Empty name]">
<P>Two randomised controlled trials were assessed as eligible for inclusion in the review. Results of the first trial (<LINK REF="STD-Heyns-1998" TYPE="STUDY">Heyns 1998</LINK>) were reported in three separate publications (<LINK REF="STD-Heyns-1998" TYPE="STUDY">Heyns 1998</LINK>; Steenkamp 1997a; Steenkamp 1997b). This trial compared urethrotomy and urethral dilatation (objective 1). The second trial compared urethrotomy and urethroplasty (objective 2) and was only reported in abstract form (<LINK REF="STD-Ravichandran-2003" TYPE="STUDY">Ravichandran 2003</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Comparison 1: urethrotomy versus urethral dilatation (including self-dilatation)</HEADING>
<P>One trial (<LINK REF="STD-Heyns-1998" TYPE="STUDY">Heyns 1998</LINK>) was included in this comparison. The publication by Steenkamp 1997a described the outcomes of first line treatment of stricture in trial participants. The publication by Heyns 1998 focused on outcomes of subsequent treatments in trial participants who suffered stricture recurrence. The second publication by Steenkamp 1997b described all outcomes. All three publications were based on a cohort of 210 adult males recruited in a large regional university hospital in South Africa. </P>
<P>Men with symptomatic strictures identified by urethrography were included irrespective of anatomical site, with only those men with complete urethral obliteration being excluded. A total of 106 men with a mean age of 49 (range 18 to 86) years were randomised to dilatation and 104 with a mean age of 50 (range 19 to 90) years were randomised to urethrotomy. All procedures were performed on an outpatient basis. Intra-urethral lidocaine gel analgesia was used but the exact type of administered anaesthesia was not clearly stated; one of the papers implied that only lidocaine gel was used as a form of analgesia as well as local anaesthesia for all cases.  Gentamicin was given as a prophylactic antibiotic in each case.</P>
<P>Urethral dilatation was performed by initial endoscopic passage of a fine filiform leader guide through the stricture; filiform followers of increasing calibre were then attached to this leader, up to a maximum of 24 French (approximately 7 mm diameter) (French is a unit for calibre measurement = external circumference in mm and therefore is divide by Pi (3.14) to get diameter). Urethrotomy was performed using a 21 French Sachse cold knife optical urethrotome (<LINK REF="REF-Kircheim-1978" TYPE="REFERENCE">Kircheim 1978</LINK>). An 18 French urethral silicon Foley catheter was then passed at the end of the procedure and removed four days later.</P>
<P>The primary outcome was the proportion of men suffering stricture recurrence as defined on repeat urethrography by a reduction in urethral calibre to less than 16 French (approximately 5 mm diameter) up to four years after the primary procedure. Secondary outcomes were complications of the respective procedures and time to stricture recurrence. For the evaluation of the initial treatment primary outcome, data were available for 151 men (72%), 74 in the dilatation group and 77 in the urethrotomy group. Subsequent analysis of the repeated treatment outcome (<LINK REF="STD-Heyns-1998" TYPE="STUDY">Heyns 1998</LINK>) had a total of 163 (78%) of the original 210 participants available for analysis. No information was given concerning the reasons for losses to follow up.</P>
<P>The study cohort was heterogenous concerning variables such as age, cause of stricture, duration of symptoms, type of presentation, positivity of urine culture prior to surgery, time elapsed between cause and presentation, anatomical site of stricture, length of stricture, and number and type of previous interventions, and there was no stratification regarding these variables at the time of randomisation. There was a claim of 'no significant difference' in terms of these variables between the urethrotomy and urethral dilatation groups. The publications stated in the methods sections that participants underwent the same treatment at recurrence as they were originally randomised to unless more than three recurrences had occurred, in which case urethroplasty was offered. The results section of Steenkamp 1997a, however, stated that most participants who suffered stricture recurrence underwent urethrotomy or urethroplasty rather than dilatation, in both groups. No details of costs or resource use were given.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Comparison 2: urethrotomy versus urethroplasty</HEADING>
<P>The abstract published by Ravichandran 2003 described the outcome of treatment for traumatic strictures of the posterior (prostato-membranous) urethra carried out in a regional teaching hospital in India. Inclusion criteria were traumatic posterior urethral strictures (distraction defects) &#8804; 2 cm in length, as estimated by urethrography performed between three and six months following injury. A total of 50 males were randomised to initial treatment by urethroplasty (25 participants) or urethrotomy (25 participants) with the primary outcome defined as the proportion of men requiring a further procedure, either self-dilatation, urethroplasty, or urethrotomy, within two years of the initial intervention. Urethroplasty was carried out using an anastomotic technique whilst the technique of urethrotomy was not fully described but was termed &#8216;core-through&#8217;. No further details of patient characteristics, methodology, completeness of follow up, costs, or resource use were given.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Comparison 3: urethroplasty versus urethral dilatation (including self-dilatation)</HEADING>
<P>No studies were identified.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2012-11-07 09:59:44 +0000" MODIFIED_BY="[Empty name]">
<P>See: 'Characteristics of excluded studies' table.</P>
<P>We considered a further 20 studies for inclusion in the review, which were subsequently considered ineligible. Four were excluded because they were not RCTs (<LINK REF="STD-Andrich-2003" TYPE="STUDY">Andrich 2003</LINK>; <LINK REF="STD-Armagan-2006" TYPE="STUDY">Armagan 2006</LINK>; <LINK REF="STD-Charbit-1990" TYPE="STUDY">Charbit 1990</LINK>; <LINK REF="STD-Marya-1992" TYPE="STUDY">Marya 1992</LINK>). </P>
<P>The remaining 16 studies were RCTs involving interventions for urethral stricture disease not prestated in our objectives.</P>
<UL>
<LI>Five of these studies (<LINK REF="STD-Bodker-1992" TYPE="STUDY">Bodker 1992</LINK>; <LINK REF="STD-Husmann-2006" TYPE="STUDY">Husmann 2006</LINK>; <LINK REF="STD-Kaisary-1985" TYPE="STUDY">Kaisary 1985</LINK>; <LINK REF="STD-Kjaergaard-1993" TYPE="STUDY">Kjaergaard 1993</LINK>; <LINK REF="STD-Mantanhelia-1995" TYPE="STUDY">Mantanhelia 1995</LINK>) described studies comparing a regimen of intermittent self-dilatation (ISD) following initial optical urethrotomy against no self-dilatation. </LI>
<LI>Three other studies (<LINK REF="STD-Harriss-1994" TYPE="STUDY">Harriss 1994</LINK>; <LINK REF="STD-Mazdak-2007" TYPE="STUDY">Mazdak 2007</LINK>; <LINK REF="STD-Tammela-1993" TYPE="STUDY">Tammela 1993</LINK>) compared short term (less than six months) against long term (up to two years) ISD following urethrotomy, with the primary outcome being time to stricture recurrence.  </LI>
<LI>One study investigated whether time to stricture recurrence was longer in men treated by urethrotomy followed by a regimen of intermittent dilatation by a physician compared to no additional treatment (<LINK REF="STD-Tunc-2002" TYPE="STUDY">Tunc 2002</LINK>).</LI>
<LI>Two studies reported comparisons between different urethrotomy procedures: <LINK REF="STD-Vincente-1990" TYPE="STUDY">Vincente 1990</LINK> compared standard cold knife optical urethrotomy with Nd-YAG laser urethrotomy whilst <LINK REF="STD-Giannakopoulos-1992" TYPE="STUDY">Giannakopoulos 1992</LINK> compared standard urethrotomy with or without additional endoscopic scar resection.</LI>
<LI>
<LINK REF="STD-Iversen-1984" TYPE="STUDY">Iversen 1984</LINK> investigated differential effects on stricture recurrence of a short (one day) or long (14 days) period of continuous indwelling urethral catheterization following urethrotomy.  </LI>
<LI>We identified five randomised studies concerning aspects of open urethroplasty. Dubey 2007 compared two graft materials, penile skin and buccal mucosa, used in bulbar urethroplasty (<LINK REF="STD-Dubey-2007" TYPE="STUDY">Dubey 2007</LINK>); whilst El-Kassaby 2008 compared the use of buccal mucosal and acellular bladder matrix graft materials (<LINK REF="STD-El_x002d_Kassaby-2008" TYPE="STUDY">El-Kassaby 2008</LINK>). </LI>
<LI>Erickson 2008 compared stricture recurrence rates in men randomised to latex or silicone indwelling urethral catheters in the immediate post-operative period following urethroplasty (<LINK REF="STD-Erickson-2008" TYPE="STUDY">Erickson 2008</LINK>); whilst Muruganandam 2009 compared closure against non-closure of the donor site wound in the mouth following use of buccal mucosa as a graft material (<LINK REF="STD-Muruganandam-2009" TYPE="STUDY">Muruganandam 2009</LINK>). Elgamal 2011 compared dorsal onlay to dorsal inlay grafts (<LINK REF="STD-Elgamal-2011" TYPE="STUDY">Elgamal 2011</LINK>).</LI>
</UL>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2012-11-07 10:00:34 +0000" MODIFIED_BY="[Empty name]">
<P>There was not enough information in either of the included trials to assess risk of bias (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>). In summary, the risk was unclear in each category.</P>
<P>In each included trial, no power calculation was evident to predetermine sample size. Baseline comparisons of relevant demographic and disease variables were reported by Steenkamp (Steenkamp 1997a), who stated that there were no significant differences. The publications by Steenkamp (Steenkamp 1997a; Steenkamp 1997b) and Heyns 1998 were based on the same patient cohort and reported some common outcomes but this was only partly clarified in the text. However, they have been reported under one trial ID (<LINK REF="STD-Heyns-1998" TYPE="STUDY">Heyns 1998</LINK>).</P>
<ALLOCATION MODIFIED="2012-11-07 10:00:14 +0000" MODIFIED_BY="[Empty name]">
<P>Neither of the two included trials reported their method of allocation. There was no pre-randomisation stratification for possible confounding factors such as site or length of stricture and number of previous treatments although post hoc analysis of trial data reported by Heyns suggested that only length of stricture had a significant effect on outcome.</P>
</ALLOCATION>
<BLINDING MODIFIED="2010-01-19 14:06:25 +0000" MODIFIED_BY="[Empty name]">
<P>Neither of the two included trials reported on blinding.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2012-11-07 10:00:26 +0000" MODIFIED_BY="[Empty name]">
<P>Reasons for incomplete follow up were not explained.</P>
<P>Heyns stated in the methods section that participants underwent the same treatment to which they were originally randomised at recurrence unless more than three recurrences had occurred, in which case urethroplasty was offered.</P>
</EXCLUSIONS>
<OTHER_BIAS_SOURCES MODIFIED="2012-11-07 10:00:34 +0000" MODIFIED_BY="[Empty name]">
<P>The statistical methods used to report data concerning recurrence and stricture-free rates were not suited to independent analysis or meta-analysis (<LINK REF="STD-Heyns-1998" TYPE="STUDY">Heyns 1998</LINK>). Median time to recurrence instead of mean was reported in Heyns 1998.</P>
<P>Ravichandran's study was only available in abstract form and, therefore, the reporting of data was understandably incomplete. Furthermore, it was unclear from the abstract what the definitions of 'success' versus 'failure' were after a study intervention, and the inclusion and exclusion criteria were not explicitly stated.</P>
<P>The studies restricted reporting of follow up to either four years (<LINK REF="STD-Heyns-1998" TYPE="STUDY">Heyns 1998</LINK>) or two years (<LINK REF="STD-Ravichandran-2003" TYPE="STUDY">Ravichandran 2003</LINK>), which may not be sufficient to encompass differential disease progression.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2012-11-07 10:03:00 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Comparison 1: urethrotomy versus urethral dilatation (including self-dilatation)</HEADING>
<P>Overall there were no statistically significant differences between the groups in any of the outcomes reported, however the confidence intervals were wide and the data were therefore unreliable.</P>
<P>The Heyns trial (<LINK REF="STD-Heyns-1998" TYPE="STUDY">Heyns 1998</LINK>) did not directly report a comparison of the primary outcome of this review for the two intervention groups, that is the proportion of men requiring further surgery for stricture recurrence after initial study treatment. Stricture-free recurrence was instead expressed graphically as a Kaplan-Meier curve but there was no accompanying data table detailing the proportions of men in each intervention group who were at risk. The cumulative recurrent stricture rates for urethrotomy compared to dilatation were reported without any supporting numerical detail. Heyns did state the median time interval from study treatment to stricture recurrence, 12 months for the urethrotomy group and six months for the dilatation group, but sufficient data to allow inclusion in a RevMan analysis were not provided.</P>
<P>Overall, intra-operative complications were more frequent in the dilatation group, however the difference was not statistically significant (dilatation 14% versus urethrotomy 11%; RR 0.75, 95% CI 0.36 to 1.55) (<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>). Tightness of stricture followed by haemorrhage were the two most common causes of complications for both intervention groups (<LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>). Tightness of stricture appeared to be more problematic among the dilatation group (dilatation 8.5% versus urethrotomy 6.7%) however this difference had wide CIs (RR 0.79, 95% CI 0.31 to 2.05). For haemorrhage, the rate was lower in the dilatation group (dilatation 2.8% versus urethrotomy 3.8%) but again the clinical significance of the difference was doubtful (RR 1.36, 95% CI 0.31 to 5.92). For false passage formation, both dilatation and urethrotomy had almost the same proportion of men experiencing the problem (dilatation 1/106 (0.94%) versus 1/104 (0.96%)) (Analysis 1.7.3).</P>
<P>Extravasation and pain seemed to be exclusively associated with the urethrotomy group (Analysis 1.7.4; Analysis 1.7.5) whilst knotting, breaking and bending of the filiform leader was associated with the dilatation group only, as expected (Analysis 1.7.6, Analysis 1.7.7, Analysis 1.7.8). As for the overall failure rate during the surgical procedure, there was again no statistically significant difference between the two intervention groups (dilatation 18% versus urethrotomy 13%; RR 0.70, 95% CI 0.36 to 1.34) (<LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>).</P>
<P>Other analyses reported in the trial using a Cox proportional hazards model suggested that, regardless of the initial study treatment, strictures longer than 2 cm were more likely to recur after initial treatment (P = 0.001); whilst anatomical site, number of strictures, and cause of stricture did not influence the recurrence rate. This report also stated that failure to successfully undertake urethrotomy was more common in men with traumatic or multiple strictures.</P>
<P>The effectiveness of a second, third, and fourth endoscopic treatment (either urethrotomy or dilatation) in men who suffered one or more stricture recurrences requiring further treatment was reported. The researchers stated that the findings did not depend on the number of previous treatments prior to randomisation (P = 0.76, statistical test not stated). The authors concluded that repeated endoscopic treatment for men suffering recurrence of urethral stricture within six months of initial treatment was not worthwhile. No other outcomes were reported. Steenkamp's paper (Steenkamp 1997b) included a comparison of effectiveness within and between the two intervention groups as bar charts. The results were stratified by clinical presentation, urine culture positivity, length and number of strictures, cause of stricture, and previous treatments. Only limited statistical information and no precise numbers of participants included were given to allow further interpretation of the data from which each bar chart was derived. It was concluded that multiple, longer (&gt; 2 cm), post-traumatic, and previously untreated strictures responded better to dilatation, whereas those men presenting with urinary retention and complications related to stricture were better treated with urethrotomy. Positive urine culture was associated with a higher intra-operative complication and failure rate. Management of previous treatment failure was also reported by Steenkamp et al (1997a).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 2: urethrotomy versus urethroplasty</HEADING>
<P>The single small trial that was eligible for this comparison was only reported in abstract form (<LINK REF="STD-Ravichandran-2003" TYPE="STUDY">Ravichandran 2003</LINK>) and therefore only limited data were available. Follow up was stated to be two years for all 50 men randomised between urethrotomy (25 men) and urethroplasty (25 men). After two years, 16 of 25 (64%) men initially treated by urethrotomy required continued self-dilatation or further surgery for stricture recurrence compared to 6 of 25 (24%) men treated by primary urethroplasty. In the primary urethroplasty group only 6 out of 25 (24%) required further intervention compared with 13 out of 16 (81%, 9 were unsuccessful at the time of the initial procedure) in the urethrotomy group for recurrent stricture at six months; this result was statistically significant (RR for recurrence of stricture requiring further surgery by six months 3.39, 95% CI 1.62 to 7.07) (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>). It appears that there were more technical failures during the procedure with urethrotomy treatment compared with urethroplasty; the result was statistically significant (RR 1.17, 95% CI 1.17 to 309.77) (<LINK REF="CMP-002.08" TYPE="ANALYSIS">Analysis 2.8</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 3: urethroplasty versus urethral dilatation (including self-dilatation)</HEADING>
<P>No studies were identified.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2012-11-07 10:05:21 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2012-11-07 10:03:22 +0000" MODIFIED_BY="[Empty name]">
<P>Our review has demonstrated that there is a clear lack of quality evidence regarding the most effective treatment for adult men with urethral stricture. Additionally the small number of included studies did not follow CONSORT guidance in reporting, limiting the opportunity for estimation of effect size and inclusion in future meta-analysis. </P>
<P>The single eligible trial comparing optical urethrotomy and urethral dilatation did not find any difference in the rates of recurrence at three years or in the median time to recurrence but the CIs were wide and the methods used for data analysis precluded secondary analysis and determination of effect size. <LINK REF="STD-Heyns-1998" TYPE="STUDY">Heyns 1998</LINK> suggested that repeated endoscopic treatment in those men suffering early recurrence within six months was not worthwhile, but again limited reporting of raw or summarised data and use of methods of analysis unsuited to secondary research prevented further exploration of the results. Stricture length was reported as a significant confounding variable and stratification using this variable may be needed in future studies.</P>
<P>The only trial including urethroplasty as a comparator was reported in abstract form with no subsequent full length publication identified (<LINK REF="STD-Ravichandran-2003" TYPE="STUDY">Ravichandran 2003</LINK>). The results of this study implied that urethrotomy was not an effective alternative to urethroplasty in the treatment of men with traumatic posterior urethral distraction injuries accompanying pelvic fractures. The lack of trials examining the comparative efficacy of endoluminal treatment (urethrotomy or dilatation) and urethroplasty for inflammatory bulbar urethral strictures is a major factor in the uncertainty with regard to treatment choice for this common condition.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2012-11-07 10:03:49 +0000" MODIFIED_BY="[Empty name]">
<P>We performed wide and relevant searches of available databases, although it is possible that we missed non-indexed publications such as those in national urological journals. The completeness of our results is suggested by the identification of other studies examining comparisons not encompassed in the present review. The limited number of relevant, eligible studies has prevented any conclusions being made regarding two of our four pre-stated comparisons. The included studies, particularly the single report considering urethroplasty, also involved a restricted population further limiting our conclusions. We found no data concerning well-being or quality of life in men with urethral stricture disease, nor any individual-level data concerning patient experience. </P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2012-11-07 10:04:44 +0000" MODIFIED_BY="[Empty name]">
<P>Reporting of raw or summarised data was limited in the included trials and hence all the risk of bias elements for both trials had to be recorded as 'unclear'. </P>
<P>In particular, the primary outcome we set out to determine, that is the failure rate of primary study treatment defined as the proportion of men requiring further surgery after primary treatment, was not directly reported in any of the three publications associated with the Heyns trial (<LINK REF="STD-Heyns-1998" TYPE="STUDY">Heyns 1998</LINK>; Steenkamp 1997a; Steenkamp 1997b). Instead of presenting simple dichotomous data such as proportions of men requiring further surgery after primary study treatment, recurrence rates were presented as more complex graphics such as life-table analysis (Steenkamp 1997a) and stricture-free &#8216;survival' Kaplan-Meier plots (<LINK REF="STD-Heyns-1998" TYPE="STUDY">Heyns 1998</LINK>). In Steenkamp's later paper (Steenkamp 1997b) there was an attempt to demonstrate the difference in stricture recurrence rates between the dilatation and urethrotomy groups, over a period of 48 months, on a bar chart. Unfortunately the actual numerical estimates of recurrence at a given point in time cannot be deduced accurately from these graphical figures. Cox&#8217;s regression analyses were presented in a publication by Steenkamp (Steenkamp 1997a) quantifying the effects of possible confounding variables including length of stricture, clinical presentation, anatomical location of stricture, and complications on the risk of stricture recurrence. However, the risks were reported for the entire cohort rather than each study treatment group. Intra-operative complication rates were reported as secondary outcomes by Steenkamp (Steenkamp 1997a; Steenkamp 1997b) but a wide range of complications were included and some were specific for a particular procedure. These factors make any conclusions concerning a comparison of overall complication rates between the procedures highly uncertain. Furthermore, in Steenkamp's publications (Steenkamp 1997a; Steenkamp 1997b) the definition of 'failure' appeared to be referring to 'intra-operative' adverse event(s) during the performance of the procedure rather than the type of failure we are interested in. Baseline comparisons between the treatment groups in each study were not adequately reported and there may have been selection bias. None of the three publications of the trial stated measures of uncertainty sufficiently (for example, SD, SE, CIs) for each outcome, which limits the opportunity for current or future meta-analysis. </P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2012-11-07 10:04:57 +0000" MODIFIED_BY="[Empty name]">
<P>The lack of raw or summarised data reported in the eligible studies prevented any secondary analysis of data in order to estimate effect size. The age of the studies (more than 10 years) made it unlikely that raw data could be obtained and this was confirmed by communication with the lead author for the larger urethrotomy study, Professor CF Heyns; authors of the study reported by Ravichandran could not be traced. </P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2012-11-07 10:05:21 +0000" MODIFIED_BY="[Empty name]">
<P>A number of narrative reviews have been published on the topic mainly summarising data from retrospective and prospective cohort studies supplemented with expert opinion from the authors (<LINK REF="REF-Andrich-2000" TYPE="REFERENCE">Andrich 2000</LINK>; <LINK REF="REF-Peterson-2004" TYPE="REFERENCE">Peterson 2004</LINK>). Their conclusions concerning the comparison between urethrotomy and dilatation were predominantly based on the trial reported by Steenkamp (Steenkamp 1997a) and Heyns 1998 and are similar to our own conclusions. The role of urethroplasty was described according to expert opinion together with the results of retrospective cases series documenting long term stricture recurrence rates following urethrotomy (<LINK REF="REF-Pansandoro-1996" TYPE="REFERENCE">Pansandoro 1996</LINK>) or urethroplasty (<LINK REF="REF-Kessler-2003" TYPE="REFERENCE">Kessler 2003</LINK>). We have not identified any previous systematic reviews.</P>
<P>We were unable to obtain any data concerning comparative cost, cost-utility or cost-effectiveness from the eligible publications. Cost comparisons using non-randomised data have been published, with one study from Nigeria favouring urethrotomy as the primary and subsequent procedure (<LINK REF="REF-Ogbonna-1998" TYPE="REFERENCE">Ogbonna 1998</LINK>), one study from the United States favouring urethroplasty as the primary procedure (<LINK REF="REF-Rourke-2005" TYPE="REFERENCE">Rourke 2005</LINK>), and one study from the United Kingdom suggesting initial urethrotomy followed by urethroplasty on recurrence as the cost-effective strategy (<LINK REF="REF-Greenwell-2004" TYPE="REFERENCE">Greenwell 2004</LINK>). The lack of comparative efficacy data from randomised studies and the lack of data regarding changes in well-being using validated instruments such as EQ-5D make the usefulness of these cost analyses uncertain.</P>
<P>It is noteworthy that a number of randomised studies examining the effectiveness of intermittent dilatation following urethrotomy carried out either by the clinician or individual patient were identified by our search strategy. Although not relevant to our pre-stated objectives, the contained data may be suitable for a subsequent systematic review and meta-analysis.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2012-11-07 10:05:45 +0000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2012-11-07 10:05:32 +0000" MODIFIED_BY="[Empty name]">
<P>The limited available evidence base suggests a shorter time to recurrent stricture formation following filiform-guided dilatation when compared to optical urethrotomy. There is also a significant reduction in the need for further intervention following urethroplasty for pelvic fractures causing urethral stricture disease compared to an increased need for further interventions following urethrotomy. These findings must be treated with extreme caution because they are from two small studies with inadequate reporting of trial design and results. There is currently no high quality evidence to guide patients and clinicians concerning the treatment of primary or recurrent urethral stricture disease. Treatment choice will, for now, continue to be based on local availability, patient and surgeon preference, and surgical expertise augmented by local audit of outcomes. </P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2012-11-07 10:05:45 +0000" MODIFIED_BY="[Empty name]">
<P>The key question as to whether endoluminal treatment by urethrotomy or dilation or open urethroplasty is the best treatment for either primary or recurrent stricture disease remains unanswered, which is unsatisfactory. </P>
<P>Research must now be concentrated on the conduct of more rigorous large, multi-centre RCTs comparing repeated urethrotomy with urethroplasty (either as a primary intervention or following failed urethrotomy). As a minimum, such trials should report on the need for further intervention, patient reported outcome measures, adverse effects, quality of life, and cost-effectiveness.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2010-03-15 11:46:32 +0000" MODIFIED_BY="[Empty name]">
<P>We thank Professor Heyns for replying to our enquiry concerning availability of raw data and making concerted but ultimately unsuccessful attempts to retrieve data files. We thank the Cochrane Incontinence Group for their support.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2010-02-12 12:22:58 +0000" MODIFIED_BY="[Empty name]">
<P>RS Pickard is a urethroplasty surgeon.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2012-09-16 22:22:15 +0100" MODIFIED_BY="[Empty name]">
<P>O Aboumarzouk and RS Pickard updated the review and edited the final manuscript.</P>
<P>S Wong acted as co-reviewer and was responsible for writing the initial manuscript.</P>
<P>RS Pickard conceived, designed and co-ordinated the review.</P>
<P>RK Narahari wrote the draft protocol and acted as co-reviewer.</P>
<P>A O'Riordan co-ordinated the initial title and protocol submission.</P>
<P>RS Pickard critically evaluated the evolving manuscript.<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2012-11-06 10:35:42 +0000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2012-11-06 10:31:08 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2012-05-27 17:41:34 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Heyns-1998" MODIFIED="2012-05-27 17:41:34 +0100" MODIFIED_BY="[Empty name]" NAME="Heyns 1998" YEAR="1998">
<REFERENCE MODIFIED="2010-01-18 11:29:58 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Heyns CF, Steenkamp JW, De Kock ML, Whitaker P</AU>
<TI>Treatment of male urethral strictures: is repeated dilation or internal urethrotomy useful?</TI>
<SO>Journal of Urology</SO>
<YR>1998</YR>
<VL>160</VL>
<NO>2</NO>
<PG>356-8</PG>
<IDENTIFIERS MODIFIED="2010-01-18 11:29:58 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-01-18 11:29:58 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="SR-INCONT8393"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-01-18 11:28:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Steenkamp JW, Heyns CF, De Kock ML</AU>
<TI>Outpatient treatment for male urethral strictures--dilatation versus internal urethrotomy</TI>
<SO>South African Journal of Surgery</SO>
<YR>1997</YR>
<VL>35</VL>
<NO>3</NO>
<PG>125-30</PG>
<IDENTIFIERS MODIFIED="2010-01-18 11:28:45 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-01-18 11:28:40 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="SR-INCONT6753"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-01-18 11:21:21 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Steenkamp JW, Heyns CF, de Kock ML</AU>
<TI>Internal urethrotomy versus dilation as treatment for male urethral strictures: a prospective, randomized comparison</TI>
<SO>Journal of Urology</SO>
<YR>1997</YR>
<VL>157</VL>
<NO>1</NO>
<PG>98-101</PG>
<IDENTIFIERS MODIFIED="2010-01-18 11:21:21 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-01-18 11:21:21 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="SR-INCONT6745"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ravichandran-2003" MODIFIED="2010-01-18 12:31:37 +0000" MODIFIED_BY="[Empty name]" NAME="Ravichandran 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-01-18 12:31:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ravichandran S, Nambirajan T, Athmalingam G</AU>
<TI>Traumatic posterior urethral stricture &#8211; a randomized study of core-through urethrotomy and anastomotic urethroplasty (Abstract number 87)</TI>
<SO>BJU International</SO>
<YR>2003</YR>
<VL>91</VL>
<NO>S2</NO>
<PG>20-1</PG>
<IDENTIFIERS MODIFIED="2010-01-18 12:31:37 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-01-18 12:31:37 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="SR-INCONT35820"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2012-11-06 10:31:08 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Andrich-2003" MODIFIED="2010-01-18 12:34:08 +0000" MODIFIED_BY="[Empty name]" NAME="Andrich 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-01-18 12:34:08 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Andrich DE, Dunglison N, Greenwell TJ, Mundy AR</AU>
<TI>The long-term results of urethroplasty</TI>
<SO>Journal of Urology</SO>
<YR>2003</YR>
<VL>170</VL>
<PG>90-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Armagan-2006" MODIFIED="2009-03-26 15:11:47 +0000" MODIFIED_BY="[Empty name]" NAME="Armagan 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-03-26 15:11:47 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Armagan A, Soyupek S, Hoscan MB, Perk H, Serel TA</AU>
<TI>Comparison of the efficacy of internal urethrotomy and benique dilations in the management of recurrent anterior and posterior urethral strictures. [Turkish]</TI>
<SO>Turk Uroloji Dergisi</SO>
<YR>2006</YR>
<VL>32</VL>
<NO>3</NO>
<PG>404-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Atak-2011" MODIFIED="2012-11-06 10:23:17 +0000" MODIFIED_BY="[Empty name]" NAME="Atak 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-11-06 10:23:17 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Atak M, Tokgöz H, Akduman B, Erol B, Dönmez I, Hanc&#305; V et al</AU>
<TI>Low-power holmium:YAG laser urethrotomy for urethral stricture disease: comparison of outcomes with the cold-knife technique</TI>
<SO>Kaohsiung Journal of Medical Sciences</SO>
<YR>2011</YR>
<VL>27</VL>
<PG>503-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bodker-1992" MODIFIED="2010-01-18 12:38:11 +0000" MODIFIED_BY="[Empty name]" NAME="Bodker 1992" YEAR="1992">
<REFERENCE MODIFIED="2010-01-18 12:38:11 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bodker A, Ostri P, Rye-Andersen J, Edvardsen L, Struckmann J</AU>
<TI>Treatment of recurrent urethral stricture by internal urethrotomy and intermittent self-catheterization: a controlled study of a new therapy</TI>
<SO>Journal of Urology</SO>
<YR>1992</YR>
<VL>148</VL>
<NO>2 Pt 1</NO>
<PG>308-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Charbit-1990" MODIFIED="2010-01-18 12:34:40 +0000" MODIFIED_BY="[Empty name]" NAME="Charbit 1990" YEAR="1990">
<REFERENCE MODIFIED="2010-01-18 12:34:40 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Charbit L, Mersel A, Beurton D, Cukier J</AU>
<TI>Five years results of internal urethrotomy for urethral stricture in adults. [French]</TI>
<SO>Annales d'Urologie</SO>
<YR>1990</YR>
<VL>24</VL>
<NO>1</NO>
<PG>66-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dahl-1986" MODIFIED="2012-11-06 10:24:06 +0000" MODIFIED_BY="[Empty name]" NAME="Dahl 1986" YEAR="1986">
<REFERENCE MODIFIED="2012-11-06 10:24:06 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dahl C, Hansen RI</AU>
<TI>Optical internal urethrotomy with and without catheter. A comparative study</TI>
<SO>Annales Chirurgiae et Gynaecologiae</SO>
<YR>1986</YR>
<VL>75</VL>
<NO>5</NO>
<PG>283-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dubey-2007" MODIFIED="2010-01-18 12:34:53 +0000" MODIFIED_BY="[Empty name]" NAME="Dubey 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-01-18 12:34:53 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dubey D, Vijjan V, Kapoor R, Srivastava A, Mandhani A, Kumar A et al</AU>
<TI>Dorsal onlay buccal mucosa versus penile skin flap urethroplasty for anterior urethral strictures: results from a randomized prospective trial</TI>
<SO>Journal of Urology</SO>
<YR>2007</YR>
<VL>178</VL>
<NO>6</NO>
<PG>2466-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Elgamal-2011" MODIFIED="2012-11-06 10:28:20 +0000" MODIFIED_BY="[Empty name]" NAME="Elgamal 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-11-06 10:28:20 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Elgamal S, Hameed HA, El-Nadey M, El Gamal O, Radwan M</AU>
<TI>Dorsal onlay (Babaglie technique) versus dorsal inlay (Asopa technique) buccal mucosal graft urethroplasty for anterior urethral stricture: A prospective randomized study</TI>
<SO>Journal of Urology</SO>
<YR>2011</YR>
<VL>184</VL>
<NO>4 Suppl 1</NO>
<PG>e84</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-El_x002d_Kassaby-2008" MODIFIED="2012-11-06 10:29:08 +0000" MODIFIED_BY="[Empty name]" NAME="El-Kassaby 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-11-06 10:29:08 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>El-Kassaby AW, AbouShwareb T, Atala A</AU>
<TI>Randomized comparative study between buccal mucosal and acellular bladder matrix grafts in complex anterior urethral strictures</TI>
<SO>Journal of Urology</SO>
<YR>2008</YR>
<VL>170</VL>
<PG>1432-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Erickson-2008" MODIFIED="2012-05-27 11:47:38 +0100" MODIFIED_BY="[Empty name]" NAME="Erickson 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-05-27 11:47:38 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Erickson BA, Navai N, Patil M, Chang A, Gonzalez CM</AU>
<TI>A prospective, randomized trial evaluating the use of hydrogel coated latex versus all silicone urethral catheters after urethral reconstructive surgery</TI>
<SO>Journal of Urology</SO>
<YR>2008</YR>
<VL>179</VL>
<PG>203-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Giannakopoulos-1992" MODIFIED="2012-11-06 10:29:23 +0000" MODIFIED_BY="[Empty name]" NAME="Giannakopoulos 1992" YEAR="1992">
<REFERENCE MODIFIED="2012-11-06 10:29:23 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Giannakopoulos X, Kammenos A</AU>
<TI>Treatment of male urethral strictures by endoscopic urethrotomy [French]</TI>
<SO>Journal d'Urologie</SO>
<YR>1992</YR>
<VL>98</VL>
<NO>4</NO>
<PG>203-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Giannakopoulos-1997" MODIFIED="2012-11-06 10:29:40 +0000" MODIFIED_BY="[Empty name]" NAME="Giannakopoulos 1997" YEAR="1997">
<REFERENCE MODIFIED="2012-11-06 10:29:40 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Giannakopoulos X, Grammeniatis E, Gartzios A, Tsoumanis P, Kammenos A</AU>
<TI>Sachse urethrotomy versus endoscopic urethrotomy plus transurethral resection of the fibrous callus (Guillemin's technique) in the treatment of urethral stricture</TI>
<SO>Urology</SO>
<YR>1997</YR>
<VL>49</VL>
<NO>2</NO>
<PG>243-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gucuk-2010" MODIFIED="2012-11-06 10:29:52 +0000" MODIFIED_BY="[Empty name]" NAME="Gucuk 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-11-06 10:29:52 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gücük A, Tuygun C, Burgu B, Oztürk U, Dede O, Imamo&#287;lu A</AU>
<TI>The short-term efficacy of dilatation therapy combined with steroid after internal urethrotomy in the management of urethral stenoses</TI>
<SO>Journal of Endourology</SO>
<YR>2010</YR>
<VL>24</VL>
<NO>6</NO>
<PG>1017-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Harriss-1994" MODIFIED="2010-01-18 12:38:35 +0000" MODIFIED_BY="[Empty name]" NAME="Harriss 1994" YEAR="1994">
<REFERENCE MODIFIED="2010-01-18 12:38:35 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harriss DR, Beckingham IJ, Lemberger RJ, Lawrence WT</AU>
<TI>Long-term results of intermittent low-friction self- catheterization in patients with recurrent urethral strictures</TI>
<SO>British Journal of Urology</SO>
<YR>1994</YR>
<VL>74</VL>
<NO>6</NO>
<PG>790-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Husmann-2006" MODIFIED="2010-01-18 12:35:45 +0000" MODIFIED_BY="[Empty name]" NAME="Husmann 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-01-18 12:35:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Husmann DA, Rathbun SR</AU>
<TI>Long-term followup of visual internal urethrotomy for management of short (less than 1 cm) penile urethral strictures following hypospadias repair</TI>
<SO>Journal of Urology</SO>
<YR>2006</YR>
<VL>176</VL>
<NO>4 Pt 2</NO>
<PG>1738-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Iversen-1984" MODIFIED="2009-03-26 15:13:08 +0000" MODIFIED_BY="[Empty name]" NAME="Iversen 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-03-26 15:13:08 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Iversen Hansen R, Reimer Jensen A</AU>
<TI>Recurrency after optical internal urethrotomy. A comparative study of long-term and short-term catheter treatment</TI>
<SO>Urologia Internationalis</SO>
<YR>1984</YR>
<VL>39</VL>
<NO>5</NO>
<PG>270-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jab_x0142_onowski-2010" MODIFIED="2012-11-06 10:30:24 +0000" MODIFIED_BY="[Empty name]" NAME="Jab&#322;onowski 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-11-06 10:30:24 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jab&#322;onowski Z, Kedzierski R, Mieko&#347; E, Sosnowski M</AU>
<TI>Comparison of neodymium-doped yttrium aluminum garnet laser treatment with cold knife endoscopic incision of urethral strictures in male patients</TI>
<SO>Photomedicine and Laser Surgery</SO>
<YR>2010</YR>
<VL>28</VL>
<NO>2</NO>
<PG>239-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kaisary-1985" MODIFIED="2009-03-26 15:13:15 +0000" MODIFIED_BY="[Empty name]" NAME="Kaisary 1985" YEAR="1985">
<REFERENCE MODIFIED="2009-03-26 15:13:15 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kaisary AV</AU>
<TI>Postoperative care following internal urethrotomy</TI>
<SO>Urology</SO>
<YR>1985</YR>
<VL>26</VL>
<NO>4</NO>
<PG>333-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kjaergaard-1993" MODIFIED="2012-11-06 10:30:44 +0000" MODIFIED_BY="[Empty name]" NAME="Kjaergaard 1993" YEAR="1994">
<REFERENCE MODIFIED="2012-11-06 10:30:44 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kjaergaard B, Walter S, Bartholin J, Andersen JT, Nohr S, Beck H et al</AU>
<TI>Prevention of urethral stricture recurrence using clean intermittent self-catheterization [see comments]</TI>
<SO>British Journal of Urology</SO>
<YR>1994</YR>
<VL>73</VL>
<NO>6</NO>
<PG>692-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lawrence-1988" MODIFIED="2012-11-06 10:30:55 +0000" MODIFIED_BY="[Empty name]" NAME="Lawrence 1988" YEAR="1988">
<REFERENCE MODIFIED="2012-11-06 10:30:55 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lawrence WT, MacDonagh RP</AU>
<TI>Treatment of urethral stricture disease by internal urethrotomy followed by intermittent 'low-friction' self-catheterization: preliminary communication</TI>
<SO>Journal of the Royal Society of Medicine</SO>
<YR>1988</YR>
<VL>81</VL>
<NO>3</NO>
<PG>136-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mantanhelia-1995" MODIFIED="2012-05-27 11:49:16 +0100" MODIFIED_BY="[Empty name]" NAME="Mantanhelia 1995" YEAR="1995">
<REFERENCE MODIFIED="2010-01-18 12:39:34 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Matanhelia SS, Salaman R, John A, Matthews PN</AU>
<TI>A prospective randomized study of self-dilatation in the management of urethral strictures</TI>
<SO>Journal of the Royal College of Surgeons of Edinburgh</SO>
<YR>1995</YR>
<VL>40</VL>
<NO>5</NO>
<PG>295-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marya-1992" MODIFIED="2010-01-18 12:35:57 +0000" MODIFIED_BY="[Empty name]" NAME="Marya 1992" YEAR="1992">
<REFERENCE MODIFIED="2010-01-18 12:35:57 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marya SK GP</AU>
<TI>Maximum flow rate-guided dilatation in patients of stricture urethra: a controlled study</TI>
<SO>Urologia Internationalis</SO>
<YR>1992</YR>
<VL>48</VL>
<NO>3</NO>
<PG>310-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mazdak-2007" MODIFIED="2012-11-06 10:31:08 +0000" MODIFIED_BY="[Empty name]" NAME="Mazdak 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-11-06 10:31:08 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mazdak H, Meshki I, Ghassami F</AU>
<TI>Effect of mitomycin C on anterior urethral stricture recurrence after internal urethrotomy [see comment]</TI>
<SO>European Urology</SO>
<YR>2007</YR>
<VL>51</VL>
<NO>4</NO>
<PG>1089-92; discussion 1092</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Muruganandam-2009" MODIFIED="2010-01-18 12:36:27 +0000" MODIFIED_BY="[Empty name]" NAME="Muruganandam 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-01-18 12:36:27 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Muruganandam K, Dubey D, Gulia AK, Mandhani A, Srivastava S, Kapoor R et al</AU>
<TI>Closure versus nonclosure of buccal mucosal graftharvest site: A prospective randomized study on postoperative morbidity</TI>
<SO>Indian Journal of Urology</SO>
<YR>2009</YR>
<VL>25</VL>
<NO>1</NO>
<PG>72-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tammela-1993" MODIFIED="2009-03-26 15:13:37 +0000" MODIFIED_BY="[Empty name]" NAME="Tammela 1993" YEAR="1993">
<REFERENCE MODIFIED="2009-03-26 15:13:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tammela TL, Permi J, Ruutu M, Talja M</AU>
<TI>Clean intermittent self-catheterization after urethrotomy for recurrent urethral strictures</TI>
<SO>Annales Chirurgiae et Gynaecologiae - Supplementum</SO>
<YR>1993</YR>
<VL>206</VL>
<PG>80-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tunc-2002" MODIFIED="2009-03-26 15:13:42 +0000" MODIFIED_BY="[Empty name]" NAME="Tunc 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-03-26 15:13:42 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tunc M, Tefekli A, Kadioglu A, Esen T, Uluocak N, Aras N</AU>
<TI>A prospective, randomized protocol to examine the efficacy of postinternal urethrotomy dilations for recurrent bulbomembranous urethral strictures</TI>
<SO>Urology</SO>
<YR>2002</YR>
<VL>60</VL>
<NO>2</NO>
<PG>239-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vincente-1990" MODIFIED="2009-03-26 15:13:46 +0000" MODIFIED_BY="[Empty name]" NAME="Vincente 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-03-26 15:13:46 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vicente J, Salvador J, Caffaratti J</AU>
<TI>Endoscopic urethrotomy versus urethrotomy plus Nd-YAG laser in the treatment of urethral stricture</TI>
<SO>European Urology</SO>
<YR>1990</YR>
<VL>18</VL>
<NO>3</NO>
<PG>166-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2012-11-06 10:35:42 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2012-11-06 10:35:42 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Andrich-2000" MODIFIED="2010-01-18 12:40:01 +0000" MODIFIED_BY="[Empty name]" NAME="Andrich 2000" TYPE="JOURNAL_ARTICLE">
<AU>Andrich DE, Mundy AR</AU>
<TI>Urethral strictures and their surgical treatment</TI>
<SO>BJU International</SO>
<YR>2000</YR>
<VL>86</VL>
<NO>5</NO>
<PG>571-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Andrich-2008" MODIFIED="2010-01-18 12:36:55 +0000" MODIFIED_BY="[Empty name]" NAME="Andrich 2008" TYPE="JOURNAL_ARTICLE">
<AU>Andrich DE, Mundy AR</AU>
<TI>What is the best technique for urethroplasty?</TI>
<SO>European Urology</SO>
<YR>2008</YR>
<VL>54</VL>
<PG>1031-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Anger-2010" MODIFIED="2012-05-27 17:24:28 +0100" MODIFIED_BY="[Empty name]" NAME="Anger 2010" TYPE="JOURNAL_ARTICLE">
<AU>Anger J, Santucci R, Grossberg A, Saigal C</AU>
<TI>The morbidity of urethral stricture disease among male Medicare beneficiaries</TI>
<SO>BMC Urology</SO>
<YR>2010</YR>
<VL>10</VL>
<NO>3</NO>
<PG>1-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Attwater-1943" MODIFIED="2010-01-18 12:37:43 +0000" MODIFIED_BY="[Empty name]" NAME="Attwater 1943" TYPE="JOURNAL_ARTICLE">
<AU>Attwater HL</AU>
<TI>History of urethral stricture</TI>
<SO>British Journal of Urology</SO>
<YR>1943</YR>
<VL>15</VL>
<PG>39-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Devereux-1970" MODIFIED="2010-01-18 12:40:49 +0000" MODIFIED_BY="[Empty name]" NAME="Devereux 1970" TYPE="JOURNAL_ARTICLE">
<AU>Devereux MH, Burfield GD</AU>
<TI>Prolonged follow up of urethral strictures treated by intermittent dilation</TI>
<SO>British Journal of Urology</SO>
<YR>1970</YR>
<VL>42</VL>
<NO>321</NO>
<PG>321-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Greenwell-2004" MODIFIED="2010-01-18 12:41:01 +0000" MODIFIED_BY="[Empty name]" NAME="Greenwell 2004" TYPE="JOURNAL_ARTICLE">
<AU>Greenwell TJ, Castle C, Andrich DE, Macdonald JT, Nicol DL, Mundy AR</AU>
<TI>Repeat urethrotomy and dilation for the treatment of urethral stricture are neither clinically effective nor cost-effective</TI>
<SO>Journal of Urology</SO>
<YR>2004</YR>
<VL>172</VL>
<PG>275-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2009" MODIFIED="2010-01-14 13:49:28 +0000" MODIFIED_BY="[Empty name]" NAME="Higgins 2009" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Versions 5.0.2 [updated September 2009]</TI>
<SO>The Cochrane Collaboration, 2009. Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Holm_x002d_Nielsen-1984" MODIFIED="2010-01-18 12:43:40 +0000" MODIFIED_BY="[Empty name]" NAME="Holm-Nielsen 1984" TYPE="JOURNAL_ARTICLE">
<AU>Holm-Nielsen A, Schultz A, Møller-Pedersen V</AU>
<TI>Direct vision internal urethrotomy. A critical review of 365 operations</TI>
<SO>British Journal of Urology</SO>
<YR>1984</YR>
<VL>56</VL>
<PG>308-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ibrahim-2012" MODIFIED="2012-05-27 17:31:28 +0100" MODIFIED_BY="[Empty name]" NAME="Ibrahim 2012" TYPE="JOURNAL_ARTICLE">
<AU>Ibrahim A, Ali N, Aliyu S, Bakari A</AU>
<TI>One-Stage Urethroplasty for strictures in Maiduguri, North Eastern Nigeria</TI>
<SO>ISRN Urology</SO>
<YR>2012</YR>
<VL>ID 847870</VL>
<PG>1-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jackson-2012" MODIFIED="2012-10-30 13:29:45 +0000" MODIFIED_BY="[Empty name]" NAME="Jackson 2012" TYPE="COCHRANE_PROTOCOL">
<AU>Jackson MJ, Veeratterapillay R, Harding C, Dorkin T</AU>
<TI>Intermittent self dilatation for urethral stricture disease in men</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>12</NO>
<IDENTIFIERS MODIFIED="2012-10-30 13:29:33 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-10-30 13:29:33 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD010258"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kessler-2003" MODIFIED="2010-01-18 12:41:33 +0000" MODIFIED_BY="[Empty name]" NAME="Kessler 2003" TYPE="JOURNAL_ARTICLE">
<AU>Kessler TM, Shreiter F, Kralidis G, Heitz M, Olianas R, Fisch M</AU>
<TI>Long-term results of surgery for urethral stricture: a statistical analysis</TI>
<SO>Journal of Urology</SO>
<YR>2003</YR>
<VL>170</VL>
<PG>840-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kircheim-1978" MODIFIED="2010-01-18 12:41:43 +0000" MODIFIED_BY="[Empty name]" NAME="Kircheim 1978" TYPE="JOURNAL_ARTICLE">
<AU>Kirchheim D, Tremann JA, Ansell JS</AU>
<TI>Transurethral urethrotomy under vision</TI>
<SO>Journal of Urology.</SO>
<YR>1978</YR>
<VL>119</VL>
<NO>4</NO>
<PG>496-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mathur-2011" MODIFIED="2012-11-06 10:31:39 +0000" MODIFIED_BY="[Empty name]" NAME="Mathur 2011" TYPE="JOURNAL_ARTICLE">
<AU>Mathur R, Aggarwal G, Satsangi B, Khan F, Odiya S</AU>
<TI>Comprehensive analysis of etiology on the prognosis of urethral strictures</TI>
<SO>International Braz J Urol</SO>
<YR>2011</YR>
<VL>37</VL>
<NO>3</NO>
<PG>362-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-O_x0027_Riordan-2008" MODIFIED="2010-01-18 12:42:01 +0000" MODIFIED_BY="[Empty name]" NAME="O'Riordan 2008" TYPE="JOURNAL_ARTICLE">
<AU>O&#8217;Riordan A, Narahari R, Kumar V, Pickard R</AU>
<TI>Outcome of dorsal buccal graft urethroplasty for recurrent bulbar urethral strictures</TI>
<SO>BJU International</SO>
<YR>2008</YR>
<VL>102</VL>
<PG>1148-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ogbonna-1998" MODIFIED="2012-11-06 10:31:51 +0000" MODIFIED_BY="[Empty name]" NAME="Ogbonna 1998" TYPE="JOURNAL_ARTICLE">
<AU>Ogbonna BC</AU>
<TI>Managing many patients with a urethral stricture: a cost-benefit analysis of treatment options</TI>
<SO>British Journal of Urology</SO>
<YR>1998</YR>
<VL>81</VL>
<NO>5</NO>
<PG>741-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pansandoro-1996" MODIFIED="2010-01-18 12:42:22 +0000" MODIFIED_BY="[Empty name]" NAME="Pansandoro 1996" TYPE="JOURNAL_ARTICLE">
<AU>Pansadoro V, Emiliozzi P</AU>
<TI>Internal urethrotomy in the management of anterior urethral strictures: long-term follow up</TI>
<SO>Journal of Urology</SO>
<YR>1996</YR>
<VL>156</VL>
<PG>73-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Peterson-2004" MODIFIED="2010-01-18 12:42:41 +0000" MODIFIED_BY="[Empty name]" NAME="Peterson 2004" TYPE="JOURNAL_ARTICLE">
<AU>Peterson AD, Webster GD</AU>
<TI>Management of urethral stricture disease: developing options for surgical intervention</TI>
<SO>BJU International</SO>
<YR>2004</YR>
<VL>94</VL>
<PG>971-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rourke-2005" MODIFIED="2010-01-18 12:42:52 +0000" MODIFIED_BY="[Empty name]" NAME="Rourke 2005" TYPE="JOURNAL_ARTICLE">
<AU>Rourke KF, Jordan GH</AU>
<TI>Primary urethral reconstruction: the cost minimized approach to the bulbous urethral stricture</TI>
<SO>Journal of Urology</SO>
<YR>2005</YR>
<VL>173</VL>
<PG>1206-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sachse-1973" MODIFIED="2012-11-06 10:35:11 +0000" MODIFIED_BY="[Empty name]" NAME="Sachse 1973" TYPE="JOURNAL_ARTICLE">
<AU>Sachse H</AU>
<TI>[Die transurethrale scharfe schlitzung der harnrohrenstriktur mit einem sichturethrotom] [German]</TI>
<SO>Verhandlungen der Deutschen Gesellschaft fur Urologie</SO>
<YR>1973</YR>
<VL>25</VL>
<PG>143</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Singh-2011" MODIFIED="2012-11-06 10:35:42 +0000" MODIFIED_BY="[Empty name]" NAME="Singh 2011" TYPE="JOURNAL_ARTICLE">
<AU>Singh O, Gupta S, Arvind N</AU>
<TI>Anterior urethral strictures: a brief review of the current surgical treatment</TI>
<SO>Urologia Internationalis</SO>
<YR>2011</YR>
<VL>86</VL>
<PG>1-10</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES MODIFIED="2009-03-26 15:13:46 +0000" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2012-11-07 11:26:23 +0000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2012-11-07 11:25:09 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2012-11-07 11:24:48 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Heyns-1998">
<CHAR_METHODS MODIFIED="2009-03-20 16:10:38 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised Controlled Trial (RCT)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-07 11:23:32 +0000" MODIFIED_BY="[Empty name]">
<P>Adult men</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-07 11:23:35 +0000" MODIFIED_BY="[Empty name]">
<P>Urethral dilatation</P>
<P>Urethrotomy (Sachse method)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-07 11:24:48 +0000" MODIFIED_BY="[Empty name]">
<P>Median time to recurrence, stricture-free rates (stratified by no. of previous treatments)</P>
<P>Recurrence rate calculated by Life-Table</P>
<P>Hazard function analyses for recurrence</P>
<P>Cox regression analyses for recurrence risk ratios, adjusted by co-factors of clinical presentation, complications during procedure, location of stricture, no. of strictures, length of stricture, no. of previous treatments</P>
<P>Failure during performance and complication rates adjusted by co-factors of urinary retention at presentation, urine culture status, no. of strictures, length of stricture, location of stricture</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-01-20 12:16:22 +0000" MODIFIED_BY="[Empty name]">
<P>Recurrence stricture rates were represented in bar chart but no exact figures or percentages were reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-07 11:25:09 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ravichandran-2003">
<CHAR_METHODS MODIFIED="2009-07-05 18:37:58 +0100" MODIFIED_BY="[Empty name]">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-07 11:24:56 +0000" MODIFIED_BY="[Empty name]">
<P>Patients with posterior urethral stricture who were treated initially with supra-pubic catheterization and had a urethrogram 3-6 months after trauma</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-07 11:25:00 +0000" MODIFIED_BY="[Empty name]">
<P>'Core-through' urethrotomy versus anastamotic urethroplasty</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-07 11:25:06 +0000" MODIFIED_BY="[Empty name]">
<P>Proportions of men requiring re-operation and/or clean intermittent self-catheterization at 3, 6, 12 and 24 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-11-07 11:25:09 +0000" MODIFIED_BY="[Empty name]">
<P>Only available in abstract form</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2012-11-07 11:26:23 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2012-11-07 11:25:16 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Andrich-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-07 11:25:16 +0000" MODIFIED_BY="[Empty name]">
<P>Not RCT, but prospective cohort comparing substituition versus anastomotic urethroplasty, children included in patient cohort</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-07 11:25:19 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Armagan-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-07 11:25:19 +0000" MODIFIED_BY="[Empty name]">
<P>Not RCT, but a prospective cohort examining the effects of urethral dilatation versus no dilatation after urethrotomy (Sachse method), on urethral stricture recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-16 22:22:54 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Atak-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-16 22:22:54 +0100" MODIFIED_BY="[Empty name]">
<P>RCT, but comparing 2 different methods of urethrotomy (Sachse and laser methods)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-07 11:25:23 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bodker-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-07 11:25:23 +0000" MODIFIED_BY="[Empty name]">
<P>RCT, but comparing effects of clean intermittent self catheterization versus no catheterization after urethrotomy (Sachse method), on urethral stricture recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-07 11:25:24 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Charbit-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-07 11:25:24 +0000" MODIFIED_BY="[Empty name]">
<P>Not RCT, but a prospective cohort study reporting outcomes following Urethrotomy after a 5-year follow up</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-07 11:25:26 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dahl-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-07 11:25:26 +0000" MODIFIED_BY="[Empty name]">
<P>RCT, but comparing 2 groups post urethrotomy, one with and the other without catheterization</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-07 11:25:28 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dubey-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-07 11:25:28 +0000" MODIFIED_BY="[Empty name]">
<P>RCT, but comparing 2 different types of urethroplasty</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-07 11:25:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-El_x002d_Kassaby-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-07 11:25:31 +0000" MODIFIED_BY="[Empty name]">
<P>RCT, but comparing 2 different type of grafts (buccal versus acellular matrix)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-07 11:25:33 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Elgamal-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-07 11:25:33 +0000" MODIFIED_BY="[Empty name]">
<P>RCT, but comparing 2 different types of graft techniques (onlay versus inlay)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-07 11:25:34 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Erickson-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-07 11:25:34 +0000" MODIFIED_BY="[Empty name]">
<P>RCT, but comparing 2 different types of urethral catheters in prevention of further urethral strictures after urethroplasty</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-03-30 22:49:06 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Giannakopoulos-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-03-30 22:49:06 +0100" MODIFIED_BY="[Empty name]">
<P>RCT, but comparing 2 different methods of urethrotomy (Sachse and Guillemin methods)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-16 22:23:13 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Giannakopoulos-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-16 22:23:13 +0100" MODIFIED_BY="[Empty name]">
<P>RCT, but comparing 2 different methods of urethrotomy (Sachse and Guillemin methods)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-07 11:25:35 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gucuk-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-07 11:25:35 +0000" MODIFIED_BY="[Empty name]">
<P>RCT, but comparing 2 different types of urethral catheters in the management of primary urethral stricture</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-07 11:25:40 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Harriss-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-07 11:25:40 +0000" MODIFIED_BY="[Empty name]">
<P>RCT, but comparing effects of short and long term clean intermittent self-catheterization after urethrotomy (Sachse method), on urethral stricture recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-07 11:25:45 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Husmann-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-07 11:25:45 +0000" MODIFIED_BY="[Empty name]">
<P>RCT, but comparing effects of urethrotomy alone versus urethrotomy plus clean intermittent self-catheterization among those with short penile urethral stricture following hypospadias repair</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-07 11:25:52 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Iversen-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-07 11:25:52 +0000" MODIFIED_BY="[Empty name]">
<P>RCT, but comparing the effects of short term (1-day) versus long term (14-day) urethral catheterization after urethrotomy, on urethral stricture recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-16 22:23:32 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jab_x0142_onowski-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-16 22:23:32 +0100" MODIFIED_BY="[Empty name]">
<P>RCT, but comparing 2 different methods of urethrotomy (Sachse and laser methods)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-07 11:25:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kaisary-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-07 11:25:57 +0000" MODIFIED_BY="[Empty name]">
<P>RCT, but comparing effects of clean intermittent self-catheterization versus no catheterization after urethrotomy (Sachse method), on urethral stricture recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-07 11:26:02 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kjaergaard-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-07 11:26:02 +0000" MODIFIED_BY="[Empty name]">
<P>RCT, but comparing effects of clean intermittent self-catheterization versus no catheterization after urethrotomy (Sachse method), on urethral stricture recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-07 11:26:03 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lawrence-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-07 11:26:03 +0000" MODIFIED_BY="[Empty name]">
<P>Not RCT, a descriptive study on the use of 'low friction' ISC following urethrotomy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-07 11:26:09 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mantanhelia-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-07 11:26:09 +0000" MODIFIED_BY="[Empty name]">
<P>RCT, but comparing effects of clean intermittent self-catheterization versus no catheterization after urethrotomy (Sachse method), on urethral stricture recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-24 19:58:00 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Marya-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-24 19:58:00 +0000" MODIFIED_BY="[Empty name]">
<P>Not RCT, but a prospective cohort study investigating into effects of maximum flow-rate guided dilatation in prevention of urethral stricture recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-07 11:26:12 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mazdak-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-07 11:26:12 +0000" MODIFIED_BY="[Empty name]">
<P>RCT, but comparing the effects of short and long term clean intermittent self-catheterization after urethrotomy (Sachse method), on urethral stricture recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-06 20:37:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Muruganandam-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-06 20:37:44 +0100" MODIFIED_BY="[Empty name]">
<P>RCT, but comparing 2 different closure methods of buccal graft harvest sites</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-07 11:26:16 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tammela-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-07 11:26:16 +0000" MODIFIED_BY="[Empty name]">
<P>RCT, but comparing effects of short and long term clean intermittent self-catheterization after urethrotomy (Sachse method), on urethral stricture recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-07 11:26:19 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tunc-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-07 11:26:19 +0000" MODIFIED_BY="[Empty name]">
<P>RCT, but comparing effects of urethral dilatation versus no dilatation after urethrotomy (Sachse method), on urethral stricture recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-07 11:26:23 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vincente-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-07 11:26:23 +0000" MODIFIED_BY="[Empty name]">
<P>RCT, but comparing the efficacy of 2 different methods of urethrotomy (endoscopic versus NdYAG laser)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2012-11-07 11:24:54 +0000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2012-05-27 17:41:29 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-24 00:50:17 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Heyns-1998">
<DESCRIPTION>
<P>No description in the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-05 18:42:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ravichandran-2003">
<DESCRIPTION>
<P>Limited by the available space of reporting in abstract form</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2012-09-16 22:22:36 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-24 00:50:23 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Heyns-1998">
<DESCRIPTION>
<P>No description in the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-16 22:22:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ravichandran-2003">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2012-09-16 22:22:39 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-03-24 00:50:27 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Heyns-1998">
<DESCRIPTION>
<P>No description in the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-09-16 22:22:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ravichandran-2003">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="GROUP" NO="9">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="GROUP" NO="10">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2012-09-16 22:22:43 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-11-24 19:52:57 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Heyns-1998">
<DESCRIPTION>
<P>Only 163/210 completed F/U. No explanation given as to what had happened to the other 47 patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-09-16 22:22:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ravichandran-2003">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="STUDY" MODIFIED="2012-11-07 11:24:54 +0000" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Selective Outcome Reporting</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-07 11:24:54 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Heyns-1998">
<DESCRIPTION>
<P>Kaplan-Meier analyses were performed to give the estimate efficacy (stricture-free rate) of treatments compared. No actual proportions of patients who were stricture-free at any one measurement/ F/U point were mentioned - and this would be the main primary outcome which would be of interest. No confidence intervals nor standard deviations were given</P>
<P>'Failure during performance' was not distinguished from 'complication during performance'</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-16 22:22:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ravichandran-2003">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="STUDY" MODIFIED="2012-05-27 17:41:29 +0100" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Other Potential Threats to Validity</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-15 13:16:27 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Heyns-1998">
<DESCRIPTION>
<P>No complication rates studied/reported. Complex statistical tests employed. Skewness of data cannot be excluded<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-05 18:43:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ravichandran-2003">
<DESCRIPTION>
<P>Unable to ascertain until the study is reported as a full article</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2012-11-07 11:26:50 +0000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2012-11-07 11:26:36 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Urethrotomy versus urethral dilatation</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-02-10 02:27:39 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Recurrence of stricture requiring further surgery</NAME>
<GROUP_LABEL_1>Urethrotomy</GROUP_LABEL_1>
<GROUP_LABEL_2>Urethral Dilatation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.02" MODIFIED="2010-02-10 02:27:09 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Interval between first treatment and need for further treatment</NAME>
<GROUP_LABEL_1>Urethrotomy</GROUP_LABEL_1>
<GROUP_LABEL_2>Urethral Dilatation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-03-05 14:50:04 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Stricutre Free Rate</NAME>
<GROUP_LABEL_1>Urethrotomy</GROUP_LABEL_1>
<GROUP_LABEL_2>Urethral Dilatation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours dilatation</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours urethrotomy</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.03.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-02-10 02:24:43 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>At 3 months</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.03.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-02-09 23:45:35 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>At 6 months</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.03.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-02-09 23:46:43 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>At 9 months</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.03.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-02-09 23:47:59 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>At 12 months</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.03.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-02-09 23:48:14 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>At 24 months</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.03.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-02-09 23:48:25 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>At 36 months</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.03.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-03-05 14:50:04 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>At 48 months</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2010-02-10 02:28:22 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Qmax (Mean ml/s)</NAME>
<GROUP_LABEL_1>Urethrotomy</GROUP_LABEL_1>
<GROUP_LABEL_2>Urethral Dilatation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-02-10 02:28:51 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Symptomatic improvement post intervention</NAME>
<GROUP_LABEL_1>Urethrotomy</GROUP_LABEL_1>
<GROUP_LABEL_2>Urethral Dilatation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="15" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-03-12 14:19:28 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="11.09" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="104" TOTAL_2="106" WEIGHT="0.0" Z="0.0">
<NAME>Adverse Events - Overall</NAME>
<GROUP_LABEL_1>Urethrotomy</GROUP_LABEL_1>
<GROUP_LABEL_2>Urethral Dilatation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Urethrotomy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Dilatation</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.550186015166472" CI_START="0.36038282845417857" EFFECT_SIZE="0.7474358974358974" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="15" LOG_CI_END="0.19038381463043344" LOG_CI_START="-0.44323591049336614" LOG_EFFECT_SIZE="-0.1264260479314663" MODIFIED="2010-01-20 11:11:37 +0000" MODIFIED_BY="[Empty name]" ORDER="3" O_E="0.0" SE="0.3721913630059435" STUDY_ID="STD-Heyns-1998" TOTAL_1="104" TOTAL_2="106" VAR="0.13852641069622204" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="18" EVENTS_2="17" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-03-12 14:19:09 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="832" TOTAL_2="848" WEIGHT="0.0" Z="0.0">
<NAME>Adverse Events During Performance of Procedure- Types of Complication</NAME>
<GROUP_LABEL_1>Urethrotomy</GROUP_LABEL_1>
<GROUP_LABEL_2>Urethral Dilatation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Urethrotomy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Dilatation</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="9" I2="0.0" ID="CMP-001.07.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-01-20 11:15:31 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="104" TOTAL_2="106" WEIGHT="0.0" Z="0.0">
<NAME>Difficult (Tight Stricture)</NAME>
<DICH_DATA CI_END="2.0497085497794787" CI_START="0.3065942463125992" EFFECT_SIZE="0.7927350427350427" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.31169211265525304" LOG_CI_START="-0.5134359995734094" LOG_EFFECT_SIZE="-0.10087194345907818" MODIFIED="2010-01-20 11:15:31 +0000" MODIFIED_BY="[Empty name]" ORDER="4" O_E="0.0" SE="0.48468433757314505" STUDY_ID="STD-Heyns-1998" TOTAL_1="104" TOTAL_2="106" VAR="0.2349189070887184" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="3" I2="0.0" ID="CMP-001.07.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-01-20 11:15:53 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="104" TOTAL_2="106" WEIGHT="0.0" Z="0.0">
<NAME>Haemorrhage/Haematoma</NAME>
<DICH_DATA CI_END="5.924121721145126" CI_START="0.31174432182206807" EFFECT_SIZE="1.358974358974359" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.772623973258789" LOG_CI_START="-0.5062014481102092" LOG_EFFECT_SIZE="0.13321126257428986" MODIFIED="2010-01-20 11:15:53 +0000" MODIFIED_BY="[Empty name]" ORDER="5" O_E="0.0" SE="0.7511883828000788" STUDY_ID="STD-Heyns-1998" TOTAL_1="104" TOTAL_2="106" VAR="0.5642839864537977" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-001.07.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-01-20 11:16:18 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="104" TOTAL_2="106" WEIGHT="0.0" Z="0.0">
<NAME>False Passage</NAME>
<DICH_DATA CI_END="16.08076728987821" CI_START="0.06460085779617131" EFFECT_SIZE="1.0192307692307692" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2063067671618113" LOG_CI_START="-1.1897617152298317" LOG_EFFECT_SIZE="0.008272525965989857" MODIFIED="2010-01-20 11:16:18 +0000" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="1.4074624872871264" STUDY_ID="STD-Heyns-1998" TOTAL_1="104" TOTAL_2="106" VAR="1.9809506531204644" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-001.07.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-01-20 11:16:34 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="104" TOTAL_2="106" WEIGHT="0.0" Z="0.0">
<NAME>Extravasation</NAME>
<DICH_DATA CI_END="104.86874686847052" CI_START="0.2475613757426429" EFFECT_SIZE="5.095238095238095" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.020646078423337" LOG_CI_START="-0.6063171125207563" LOG_EFFECT_SIZE="0.7071644829512903" MODIFIED="2010-01-20 11:16:34 +0000" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="1.5430911820380762" STUDY_ID="STD-Heyns-1998" TOTAL_1="104" TOTAL_2="106" VAR="2.381130396083667" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="0" I2="0.0" ID="CMP-001.07.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-01-20 11:16:55 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="104" TOTAL_2="106" WEIGHT="0.0" Z="0.0">
<NAME>Pain</NAME>
<DICH_DATA CI_END="168.24204610842446" CI_START="0.49996480657758935" EFFECT_SIZE="9.17142857142857" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.225934541467343" LOG_CI_START="-0.30106056535815046" LOG_EFFECT_SIZE="0.9624369880545964" MODIFIED="2010-01-20 11:16:55 +0000" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.0" SE="1.4843694345768137" STUDY_ID="STD-Heyns-1998" TOTAL_1="104" TOTAL_2="106" VAR="2.2033526183058894" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="2" I2="0.0" ID="CMP-001.07.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-02-11 00:41:47 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="104" TOTAL_2="106" WEIGHT="0.0" Z="0.0">
<NAME>Knotting of Filiform Leader</NAME>
<DICH_DATA CI_END="4.194749874738821" CI_START="0.009902455029705713" EFFECT_SIZE="0.2038095238095238" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6227060697512994" LOG_CI_START="-2.004257121192794" LOG_EFFECT_SIZE="-0.6907755257207473" MODIFIED="2010-02-11 00:41:47 +0000" MODIFIED_BY="[Empty name]" ORDER="9" O_E="0.0" SE="1.5430911820380762" STUDY_ID="STD-Heyns-1998" TOTAL_1="104" TOTAL_2="106" VAR="2.381130396083667" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-001.07.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-02-11 00:41:48 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="104" TOTAL_2="106" WEIGHT="0.0" Z="0.0">
<NAME>Breaking of Filiform Leader</NAME>
<DICH_DATA CI_END="8.244282779363349" CI_START="0.013995665948529062" EFFECT_SIZE="0.3396825396825397" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9161528796878264" LOG_CI_START="-1.854006431896608" LOG_EFFECT_SIZE="-0.4689267761043909" MODIFIED="2010-02-11 00:41:48 +0000" MODIFIED_BY="[Empty name]" ORDER="10" O_E="0.0" SE="1.6272052921344415" STUDY_ID="STD-Heyns-1998" TOTAL_1="104" TOTAL_2="106" VAR="2.6477970627503336" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-001.07.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-02-11 00:41:52 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="104" TOTAL_2="106" WEIGHT="0.0" Z="0.0">
<NAME>Bending of Filiform Leader</NAME>
<DICH_DATA CI_END="8.244282779363349" CI_START="0.013995665948529062" EFFECT_SIZE="0.3396825396825397" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9161528796878264" LOG_CI_START="-1.854006431896608" LOG_EFFECT_SIZE="-0.4689267761043909" MODIFIED="2010-02-11 00:41:49 +0000" MODIFIED_BY="[Empty name]" ORDER="11" O_E="0.0" SE="1.6272052921344415" STUDY_ID="STD-Heyns-1998" TOTAL_1="104" TOTAL_2="106" VAR="2.6477970627503336" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="13" EVENTS_2="19" I2="0.0" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2012-08-30 09:51:25 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="104" TOTAL_2="106" WEIGHT="0.0" Z="0.0">
<NAME>technical failure during procedure (procedure abandoned)</NAME>
<GROUP_LABEL_1>Urethrotomy</GROUP_LABEL_1>
<GROUP_LABEL_2>Urethral Dilatation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Urethrotomy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Dilatation</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3378936064137943" CI_START="0.3634987956815355" EFFECT_SIZE="0.6973684210526315" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="19" LOG_CI_END="0.12642157831627307" LOG_CI_START="-0.4394970236762777" LOG_EFFECT_SIZE="-0.15653772268000235" MODIFIED="2010-01-20 11:21:09 +0000" MODIFIED_BY="[Empty name]" ORDER="12" O_E="0.0" SE="0.3324233881526837" STUDY_ID="STD-Heyns-1998" TOTAL_1="104" TOTAL_2="106" VAR="0.1105053089909098" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.09" MODIFIED="2010-03-05 14:08:38 +0000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Length of Hospital Stay</NAME>
<GROUP_LABEL_1>Urethrotomy</GROUP_LABEL_1>
<GROUP_LABEL_2>Urethral Dilatation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Urethrotomy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Dilatation</GRAPH_LABEL_2>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.10" MODIFIED="2010-03-05 14:08:38 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Length of Catheterisation</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.11" MODIFIED="2010-03-05 14:08:38 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Operative Time</NAME>
<GROUP_LABEL_1>Urethrotomy</GROUP_LABEL_1>
<GROUP_LABEL_2>Urethral Dilatation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.12" MODIFIED="2010-03-05 14:08:38 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Quality of Life</NAME>
<GROUP_LABEL_1>Urethrotomy</GROUP_LABEL_1>
<GROUP_LABEL_2>Urethral Dilatation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.13" MODIFIED="2010-03-05 14:08:38 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Costs, Resource Use and formal measures of cost-effectiveness</NAME>
<GROUP_LABEL_1>Urethrotomy</GROUP_LABEL_1>
<GROUP_LABEL_2>Urethral Dilatation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2012-11-07 11:26:50 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Urethrotomy versus urethroplasty</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="17" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-03-12 15:04:20 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="48" TOTAL_2="75" WEIGHT="0.0" Z="0.0">
<NAME>Recurrence of stricture requiring further surgery</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours urethrotomy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours urethroplasty</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="13" EVENTS_2="6" I2="0.0" ID="CMP-002.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-03-05 14:16:05 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>at six months</NAME>
<DICH_DATA CI_END="7.0687028515576165" CI_START="1.6213789499468003" EFFECT_SIZE="3.3854166666666665" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="6" LOG_CI_END="0.8493397255230554" LOG_CI_START="0.20988453035555643" LOG_EFFECT_SIZE="0.5296121279393059" MODIFIED="2010-03-05 14:16:05 +0000" MODIFIED_BY="[Empty name]" ORDER="18" O_E="0.0" SE="0.37561914699565513" STUDY_ID="STD-Ravichandran-2003" TOTAL_1="16" TOTAL_2="25" VAR="0.14108974358974358" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-002.01.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-03-05 14:16:16 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>at one year</NAME>
<DICH_DATA CI_END="149.6811672810001" CI_START="0.3906804691116402" EFFECT_SIZE="7.647058823529412" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.175167161328675" LOG_CI_START="-0.4081782994715495" LOG_EFFECT_SIZE="0.8834944309285628" MODIFIED="2010-03-05 14:16:16 +0000" MODIFIED_BY="[Empty name]" ORDER="19" O_E="0.0" SE="1.5174699114403214" STUDY_ID="STD-Ravichandran-2003" TOTAL_1="16" TOTAL_2="25" VAR="2.302714932126697" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-002.01.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-03-05 14:20:05 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>at two years</NAME>
<DICH_DATA CI_END="149.6811672810001" CI_START="0.3906804691116402" EFFECT_SIZE="7.647058823529412" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.175167161328675" LOG_CI_START="-0.4081782994715495" LOG_EFFECT_SIZE="0.8834944309285628" MODIFIED="2010-03-05 14:20:05 +0000" MODIFIED_BY="[Empty name]" ORDER="20" O_E="0.0" SE="1.5174699114403214" STUDY_ID="STD-Ravichandran-2003" TOTAL_1="16" TOTAL_2="25" VAR="2.302714932126697" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.02" MODIFIED="2010-01-18 10:41:38 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Interval between first treatment and need for further treatment</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2009-03-23 23:07:21 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Stricutre Free Rate</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2010-03-05 14:21:41 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>flow rate - Qmax (Mean ml/s)</NAME>
<GROUP_LABEL_1>Buccal Graft</GROUP_LABEL_1>
<GROUP_LABEL_2>Acellular Matrix Graft</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2009-03-23 23:08:03 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Symptomatic improvement post intervention</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2009-03-24 00:10:42 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Adverse Events - Overall</NAME>
<GROUP_LABEL_1>Urethrotomy</GROUP_LABEL_1>
<GROUP_LABEL_2>Urethral Dilatation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Urethrotomy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Dilatation</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-03-12 14:16:52 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Adverse Events - Types of Complication</NAME>
<GROUP_LABEL_1>Urethrotomy</GROUP_LABEL_1>
<GROUP_LABEL_2>Urethroplasty</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Urethrotomy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Urethroplasty</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.07.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2009-03-24 00:10:50 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Difficult (Tight Stricture)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.07.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2009-03-24 00:10:55 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Haemorrhage</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.07.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2009-03-24 00:11:00 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>False Passage</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.07.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2009-03-24 00:11:06 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Extravasation</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.07.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2009-03-24 00:11:14 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Pain</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.07.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2009-03-24 00:11:22 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Knotting of Filiform Leader</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.07.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2009-03-24 00:11:27 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Breaking of Filiform Leader</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.07.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2009-03-24 00:11:41 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Bending of Filiform Leader</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-002.07.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-03-05 14:51:05 +0000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>Sepsis</NAME>
<DICH_DATA CI_END="99.16103229177347" CI_START="0.25211516482038504" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9963410392362373" LOG_CI_START="-0.5984010305641998" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2010-03-05 14:51:05 +0000" MODIFIED_BY="[Empty name]" ORDER="21" O_E="0.0" SE="1.5241643359811707" STUDY_ID="STD-Ravichandran-2003" TOTAL_1="25" TOTAL_2="25" VAR="2.3230769230769233" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-002.07.10" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-03-05 14:23:52 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>Rectal Injury</NAME>
<DICH_DATA CI_END="70.29633525231901" CI_START="0.12802943379190032" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8469326846047245" LOG_CI_START="-0.8926901751653995" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2010-03-05 14:23:52 +0000" MODIFIED_BY="[Empty name]" ORDER="22" O_E="0.0" SE="1.6092680291808414" STUDY_ID="STD-Ravichandran-2003" TOTAL_1="25" TOTAL_2="25" VAR="2.58974358974359" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-03-12 14:15:58 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="25" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>technical failure during procedure (procedure abandoned)</NAME>
<GROUP_LABEL_1>Urethrotomy</GROUP_LABEL_1>
<GROUP_LABEL_2>Urethroplasty</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Urethrotomy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Urethroplasty</GRAPH_LABEL_2>
<DICH_DATA CI_END="309.76559330296396" CI_START="1.1653973449753874" EFFECT_SIZE="19.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="0" LOG_CI_END="2.4910331775661927" LOG_CI_START="0.066474024339465" LOG_EFFECT_SIZE="1.2787536009528289" MODIFIED="2010-03-05 14:26:22 +0000" MODIFIED_BY="[Empty name]" ORDER="22" O_E="0.0" SE="1.4241980483667502" STUDY_ID="STD-Ravichandran-2003" TOTAL_1="25" TOTAL_2="25" VAR="2.02834008097166" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.09" MODIFIED="2010-03-05 14:26:50 +0000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Length of Hospital Stay</NAME>
<GROUP_LABEL_1>Urethrotomy</GROUP_LABEL_1>
<GROUP_LABEL_2>Urethral Dilatation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Urethrotomy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Dilatation</GRAPH_LABEL_2>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.10" MODIFIED="2010-03-05 14:26:50 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Length of Catheterisation</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.11" MODIFIED="2010-03-05 14:26:50 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Operative Time</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.12" MODIFIED="2010-03-05 14:26:50 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Quality of Life</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.13" MODIFIED="2010-03-05 14:26:50 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Costs, Resource Use and formal measures of cost-effectiveness</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2012-11-07 11:27:17 +0000" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="1.jpg" FILE_TYPE="JPG" ID="FIG-01" MODIFIED="2012-11-07 11:27:17 +0000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Flow chart of article selection process.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2012-11-07 11:24:55 +0000" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2012-11-07 11:24:55 +0000" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2012-11-07 11:27:33 +0000" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2012-11-07 11:27:33 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2009-03-26 13:02:37 +0000" MODIFIED_BY="[Empty name]">Search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2012-11-07 11:27:33 +0000" MODIFIED_BY="[Empty name]">
<P>For this review additional searches were performed by the Trials Search Co-ordinator. These are detailed below.</P>
<P>The following databases were searched:</P>
<UL>
<LI>CENTRAL on Ovid (2012, Issue 6), searched on 21 June 2012.</LI>
</UL>
<P>The search strategy used was:</P>
<TABLE COLS="2" ROWS="20">
<TR>
<TD>
<P>1.</P>
</TD>
<TD>
<P>urethrotom$.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>2.</P>
</TD>
<TD>
<P>(dilatat$ adj25 urethra$).tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>3.</P>
</TD>
<TD>
<P>(self adj3 calibrat$).tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>4.</P>
</TD>
<TD>
<P>self dilatat$.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>5.</P>
</TD>
<TD>
<P>urethroplast$.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>6.</P>
</TD>
<TD>
<P>urethral stricture/</P>
</TD>
</TR>
<TR>
<TD>
<P>7.</P>
</TD>
<TD>
<P>(urethra$ adj5 (stricture$ or stenos$)).tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>8.</P>
</TD>
<TD>
<P>(urethra$ adj3 narrow$).tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>9.</P>
</TD>
<TD>
<P>or/1-8</P>
</TD>
</TR>
<TR>
<TD>
<P>10.</P>
</TD>
<TD>
<P>cochrane incontinence group.gc.</P>
</TD>
</TR>
<TR>
<TD>
<P>11.</P>
</TD>
<TD>
<P>9 not 10</P>
</TD>
</TR>
<TR>
<TD>
<P>12.</P>
</TD>
<TD>
<P>((urin$ or urethra$) adj5 catheter$).tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>13.</P>
</TD>
<TD>
<P>((intermittent or bladder) adj5 catheter$).tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>14.</P>
</TD>
<TD>
<P>dilatat$.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>15.</P>
</TD>
<TD>
<P>calibrat$.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>16.</P>
</TD>
<TD>
<P>or/12-15</P>
</TD>
</TR>
<TR>
<TD>
<P>17.</P>
</TD>
<TD>
<P>or/6-8</P>
</TD>
</TR>
<TR>
<TD>
<P>18.</P>
</TD>
<TD>
<P>16 and 17</P>
</TD>
</TR>
<TR>
<TD>
<P>19.</P>
</TD>
<TD>
<P>18 not 10</P>
</TD>
</TR>
<TR>
<TD>
<P>20.</P>
</TD>
<TD>
<P>11 or 19</P>
</TD>
</TR>
</TABLE>
<UL>
<LI>MEDLINE on Ovid (January 1946 to Week 2 June 2012), and MEDLINE In Process on Ovid (20 June 2012), were searched on 21 June 2012.</LI>
</UL>
<P>The search strategy used was:</P>
<TABLE COLS="2" ROWS="35">
<TR>
<TD>
<P>1.</P>
</TD>
<TD>
<P>controlled clinical trial.pt.</P>
</TD>
</TR>
<TR>
<TD>
<P>2.</P>
</TD>
<TD>
<P>randomized controlled trial.pt.</P>
</TD>
</TR>
<TR>
<TD>
<P>3.</P>
</TD>
<TD>
<P>randomized controlled trials/</P>
</TD>
</TR>
<TR>
<TD>
<P>4.</P>
</TD>
<TD>
<P>random allocation/</P>
</TD>
</TR>
<TR>
<TD>
<P>5.</P>
</TD>
<TD>
<P>double blind method/</P>
</TD>
</TR>
<TR>
<TD>
<P>6.</P>
</TD>
<TD>
<P>single blind method/</P>
</TD>
</TR>
<TR>
<TD>
<P>7.</P>
</TD>
<TD>
<P>clinical trial.pt.</P>
</TD>
</TR>
<TR>
<TD>
<P>8.</P>
</TD>
<TD>
<P>exp clinical trials/</P>
</TD>
</TR>
<TR>
<TD>
<P>9.</P>
</TD>
<TD>
<P>placebos/</P>
</TD>
</TR>
<TR>
<TD>
<P>10.</P>
</TD>
<TD>
<P>placebo$.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>11.</P>
</TD>
<TD>
<P>random$.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>12.</P>
</TD>
<TD>
<P>research design/</P>
</TD>
</TR>
<TR>
<TD>
<P>13.</P>
</TD>
<TD>
<P>volunteer$.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>14.</P>
</TD>
<TD>
<P>(clin$ adj25 trial$).tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>15.</P>
</TD>
<TD>
<P>((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>16.</P>
</TD>
<TD>
<P>factorial.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>17.</P>
</TD>
<TD>
<P>cross-over studies/</P>
</TD>
</TR>
<TR>
<TD>
<P>18.</P>
</TD>
<TD>
<P>crossover.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>19.</P>
</TD>
<TD>
<P>latin square.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>20.</P>
</TD>
<TD>
<P>(balance$ adj2 block$).tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>21.</P>
</TD>
<TD>
<P>(animals not humans).sh.</P>
</TD>
</TR>
<TR>
<TD>
<P>22.</P>
</TD>
<TD>
<P>or/1-20</P>
</TD>
</TR>
<TR>
<TD>
<P>23.</P>
</TD>
<TD>
<P>22 not 21</P>
</TD>
</TR>
<TR>
<TD>
<P>24.</P>
</TD>
<TD>
<P>exp clinical trial/</P>
</TD>
</TR>
<TR>
<TD>
<P>25.</P>
</TD>
<TD>
<P>clinical trials as topic/ or clinical trials, phase i as topic/ or clinical trials, phase ii as topic/ or clinical trials, phase iii as topic/ or clinical trials, phase iv as topic/ or controlled clinical trials as topic/ or randomized controlled trials as topic/ or multicenter studies as topic/</P>
</TD>
</TR>
<TR>
<TD>
<P>26.</P>
</TD>
<TD>
<P>or/1-20,24-25</P>
</TD>
</TR>
<TR>
<TD>
<P>27.</P>
</TD>
<TD>
<P>26 not 21</P>
</TD>
</TR>
<TR>
<TD>
<P>28.</P>
</TD>
<TD>
<P>urethrotom$.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>29.</P>
</TD>
<TD>
<P>(dilatat$ adj25 urethra$).tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>30.</P>
</TD>
<TD>
<P>self dilatat$.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>31.</P>
</TD>
<TD>
<P>urethroplast$.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>32.</P>
</TD>
<TD>
<P>urethral stricture/</P>
</TD>
</TR>
<TR>
<TD>
<P>33.</P>
</TD>
<TD>
<P>(urethra$ adj5 (stricture$ or stenos$)).tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>34.</P>
</TD>
<TD>
<P>or/28-33</P>
</TD>
</TR>
<TR>
<TD>
<P>35.</P>
</TD>
<TD>
<P>34 and 27</P>
</TD>
</TR>
</TABLE>
<UL>
<LI>EMBASE on Ovid (January 1980 to Week 25, 2012), searched on 25 June 2012.</LI>
</UL>
<P>The search strategy used was:</P>
<TABLE COLS="2" ROWS="51">
<TR>
<TD>
<P>1.</P>
</TD>
<TD>
<P>Randomized Controlled Trial/</P>
</TD>
</TR>
<TR>
<TD>
<P>2.</P>
</TD>
<TD>
<P>controlled study/</P>
</TD>
</TR>
<TR>
<TD>
<P>3.</P>
</TD>
<TD>
<P>clinical study/</P>
</TD>
</TR>
<TR>
<TD>
<P>4.</P>
</TD>
<TD>
<P>major clinical study/</P>
</TD>
</TR>
<TR>
<TD>
<P>5.</P>
</TD>
<TD>
<P>prospective study/</P>
</TD>
</TR>
<TR>
<TD>
<P>6.</P>
</TD>
<TD>
<P>meta analysis/</P>
</TD>
</TR>
<TR>
<TD>
<P>7.</P>
</TD>
<TD>
<P>exp clinical trial/</P>
</TD>
</TR>
<TR>
<TD>
<P>8.</P>
</TD>
<TD>
<P>randomization/</P>
</TD>
</TR>
<TR>
<TD>
<P>9.</P>
</TD>
<TD>
<P>crossover procedure/ or double blind procedure/ or parallel design/ or single blind procedure/</P>
</TD>
</TR>
<TR>
<TD>
<P>10.</P>
</TD>
<TD>
<P>Placebo/</P>
</TD>
</TR>
<TR>
<TD>
<P>11.</P>
</TD>
<TD>
<P>latin square design/</P>
</TD>
</TR>
<TR>
<TD>
<P>12.</P>
</TD>
<TD>
<P>exp comparative study/</P>
</TD>
</TR>
<TR>
<TD>
<P>13.</P>
</TD>
<TD>
<P>follow up/</P>
</TD>
</TR>
<TR>
<TD>
<P>14.</P>
</TD>
<TD>
<P>pilot study/</P>
</TD>
</TR>
<TR>
<TD>
<P>15.</P>
</TD>
<TD>
<P>family study/ or feasibility study/ or pilot study/ or study/</P>
</TD>
</TR>
<TR>
<TD>
<P>16.</P>
</TD>
<TD>
<P>placebo$.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>17.</P>
</TD>
<TD>
<P>random$.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>18.</P>
</TD>
<TD>
<P>(clin$ adj25 trial$).tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>19.</P>
</TD>
<TD>
<P>((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>20.</P>
</TD>
<TD>
<P>factorial.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>21.</P>
</TD>
<TD>
<P>crossover.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>22.</P>
</TD>
<TD>
<P>latin square.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>23.</P>
</TD>
<TD>
<P>(balance$ adj2 block$).tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>24.</P>
</TD>
<TD>
<P>or/1-23</P>
</TD>
</TR>
<TR>
<TD>
<P>25.</P>
</TD>
<TD>
<P>(nonhuman not human).sh.</P>
</TD>
</TR>
<TR>
<TD>
<P>26.</P>
</TD>
<TD>
<P>24 not 25</P>
</TD>
</TR>
<TR>
<TD>
<P>27.</P>
</TD>
<TD>
<P>factorial design/</P>
</TD>
</TR>
<TR>
<TD>
<P>28.</P>
</TD>
<TD>
<P>parallel design/</P>
</TD>
</TR>
<TR>
<TD>
<P>29.</P>
</TD>
<TD>
<P>triple blind procedure/</P>
</TD>
</TR>
<TR>
<TD>
<P>30.</P>
</TD>
<TD>
<P>community trial/</P>
</TD>
</TR>
<TR>
<TD>
<P>31.</P>
</TD>
<TD>
<P>intervention study/</P>
</TD>
</TR>
<TR>
<TD>
<P>32.</P>
</TD>
<TD>
<P>experimental study/</P>
</TD>
</TR>
<TR>
<TD>
<P>33.</P>
</TD>
<TD>
<P>prevention study/</P>
</TD>
</TR>
<TR>
<TD>
<P>34.</P>
</TD>
<TD>
<P>quasi experimental study/</P>
</TD>
</TR>
<TR>
<TD>
<P>35.</P>
</TD>
<TD>
<P>or/27-34</P>
</TD>
</TR>
<TR>
<TD>
<P>36.</P>
</TD>
<TD>
<P>24 or 35</P>
</TD>
</TR>
<TR>
<TD>
<P>37.</P>
</TD>
<TD>
<P>36 not 25</P>
</TD>
</TR>
<TR>
<TD>
<P>38.</P>
</TD>
<TD>
<P>urethra stricture/</P>
</TD>
</TR>
<TR>
<TD>
<P>39.</P>
</TD>
<TD>
<P>urethra stenosis/</P>
</TD>
</TR>
<TR>
<TD>
<P>40.</P>
</TD>
<TD>
<P>(urethra$ adj5 (stricture$ or stenos$)).tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>41.</P>
</TD>
<TD>
<P>(urethra$ adj5 narrow$).tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>42.</P>
</TD>
<TD>
<P>41 or 38 or 39 or 40</P>
</TD>
</TR>
<TR>
<TD>
<P>43.</P>
</TD>
<TD>
<P>urethroplasty/ or urethrotomy/</P>
</TD>
</TR>
<TR>
<TD>
<P>44.</P>
</TD>
<TD>
<P>urethroplast$.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>45.</P>
</TD>
<TD>
<P>urethrotom$.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>46.</P>
</TD>
<TD>
<P>dilatat$.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>47.</P>
</TD>
<TD>
<P>intermittent catheterization/</P>
</TD>
</TR>
<TR>
<TD>
<P>48.</P>
</TD>
<TD>
<P>catheter$.tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>49.</P>
</TD>
<TD>
<P>bladder catheterization/ or urethral catheterization/</P>
</TD>
</TR>
<TR>
<TD>
<P>50.</P>
</TD>
<TD>
<P>49 or 46 or 45 or 43 or 44 or 48 or 47</P>
</TD>
</TR>
<TR>
<TD>
<P>51.</P>
</TD>
<TD>
<P>42 and 50 and 37</P>
</TD>
</TR>
</TABLE>
<UL>
<LI>OpenSIGLE (searched 26 June 2012), searched on 26 June 2012.</LI>
</UL>
<P>The search terms used were:</P>
<P>urethra* stricture*</P>
<P>urethra* stenos*</P>
<P>urethra* narrow*</P>
<P>Also the following clinical trials registries/platforms were all searched on 26 June 2012:</P>
<UL>
<LI>WHO International Clinical Trials Registry Platform (ICTRP)</LI>
<LI>Current Controlled Trials (including the UK National Research Register)</LI>
<LI>ClinicalTrials.gov</LI>
</UL>
<P>The search terms used were the same for all three databases:</P>
<P>urethra* stricture*</P>
<P>urethra* stenos*</P>
<P>urethra* narrow*</P>
<P>MeSH Phrases used</P>
<UL>
<LI>("Urethral Stricture"[Mesh]) AND "Randomized Controlled Trial" [Publication Type])</LI>
<LI>(("Urethral Stricture"[Mesh]) AND "Randomized Controlled Trial" [Publication Type]) AND "Catheterization"[Mesh])</LI>
<LI>(("Urethral Stricture"[Mesh]) AND "Randomized Controlled Trial" [Publication Type]) AND "Surgical Procedures, Operative"[Mesh])</LI>
</UL>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>